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Thesis abstract  
 
This thesis focuses on psychosocial interventions for psychosis. It consists of two 
parts: a systematic review on quality of life in forensic settings and an empirical 
study on negative symptoms. The systematic review follows the publication 
guidelines of the journal International Journal of Forensic Mental Health whilst the 
empirical study follows the publication guidelines of the journal Clinical Psychology 
and Psychotherapy. Reasonable adjustments have been made to the formatting of 
this thesis to enhance readability.  
 
Purpose: The systematic literature review aimed to summarise and critically 
appraise studies that have evaluated the effects of psychosocial interventions for 
psychotic disorders in forensic settings on quality of life. The empirical study aimed 
to evaluate the feasibility of Metacognitive Training (MCT) for negative symptoms 
and to identify mechanisms of change.  
 
Methods: The literature was systematically searched (using four databases) for 
research that included any quantitative measure of quality of life (i.e. self-esteem, 
quality of life, life satisfaction, and/or self-efficacy in relation to life-goals). In the 
empirical study, a new intervention was developed by modifying MCT for negative 
symptoms and four aspects of feasibility were evaluated: acceptability, practicality, 
demand and limited efficacy. The quantitative approach was supplemented with 
qualitative interviews on participants’ views of the intervention. In addition, 
potential mechanisms of change were evaluated using a promising new method for 




Results: In total, 10 papers met the inclusion criteria in the systematic review. 
Significant improvements in quality of life were found in five studies. The modified 
version of MCT showed good feasibility as demonstrated by the attendance rate, the 
positive oral feedback from participants and the multidisciplinary team, and the 
improvements on negative symptoms that were found following the intervention. 
Multilevel modeling proved useful in explaining the variance attributable to three 
different predictors: depression, internalised stigma, and reflective functioning.      
 
Conclusions: It was found that quality of life can be improved in forensic settings 
using psychosocial interventions. The pilot study indicated that MCT for negative 
symptoms has high feasibility and that changes in negative symptoms can partially 







Introduction: Interventions for patients with psychosis in forensic settings tend to 
focus on symptom reduction and the risk of re-offending. However, it can be argued 
that this focus on deficits fails to take into account the value of developing and 
enhancing the individual’s existing skills. During the last 20 years, an interest in 
individual potential and resilience has developed within research on mental 
wellbeing.  
 
Aims: This systematic review aimed to systematically summarise the literature and 
critically appraise studies that have evaluated psychosocial interventions for 
psychotic disorders in forensic settings that included any quantitative measure of 
quality of life (i.e. self-esteem, quality of life, life satisfaction, and/or self-efficacy in 
relation to life-goals). 
 
Main findings: Overall, five of the ten identified studies found significant 
improvements in quality of life following the intervention. 
 
Conclusions: It was found that quality of life can be improved in forensic settings 
using psychosocial interventions. Though the results were encouraging, further 






Introduction: The second part of this thesis is an empirical study focusing on 
negative symptoms. Negative symptoms typically include: emotional flattening; 
poverty of speech; loss of interest and motivation; inability to feel pleasure in 
normally pleasurable activities; and social withdrawal. Negative symptoms may 
develop as a coping strategy, where the shutting down of psychological systems 
allows the individual to cope with overwhelming situations. Disengagement might 
then be maintained by certain dysfunctional beliefs (e.g. low expectations of 
pleasure, success or acceptance) that can arise as a consequence of stigma. As 
depression typically co-exists with negative symptoms, it has been hypothesised that 
depression might by more than a co-morbid condition. In addition, it has been 
suggested that negative symptoms might be related to metacognitive functioning (i.e. 
the ability to think about oneself and others in a complex way).  
 
Aims: Metacognitive training (MCT) is an intervention that aims to improve insight 
into cognitive processes. As the intervention is designed for positive symptoms in 
schizophrenia, the main author of this study created a modified version to address 
negative symptoms. The purpose of this study is to evaluate four aspects of the 
feasibility of the modified version of MCT for negative symptoms: acceptability, 
practicality, demand and limited efficacy. It also aims to investigate whether 
internalised stigma, depression, and metacognitive functioning have an impact on 




Main findings: The modified version of MCT showed good feasibility as 
demonstrated by the attendance rate, the positive oral feedback from participants and 
the multidisciplinary team, and the improvements on negative symptoms that were 
found following the intervention. It was also found that stigma explained more of the 
improvement on negative symptoms than depression whilst metacognitive 
functioning explained more than both depression and stigma.  
 
Conclusions: The empirical study suggests that MCT can be used for targeting 
negative symptoms and that the intervention has good overall feasibility. The 
promising results in terms of outcomes suggest the intervention should be systematically 
assessed in future research with a larger sample, a control group, and an independent 
research group.   
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Quality of Life (QoL) in forensic services is an important topic given the emphasis 
on recovery in mental health. The aim of this review is to systematically review the 
literature and critically appraise studies that evaluated psychosocial interventions for 
psychotic disorders in forensic settings that included quantitative measures of QoL. 
Overall, five of the ten identified studies found significant improvements in QoL 
following the intervention. Whilst these findings were encouraging, the 
heterogeneity and the quality of the included studies prevented any firm conclusions. 
Further research on QoL for the forensic population is needed.  
 






1.1. Psychosocial interventions in forensic settings 
 
 
As pointed out in the literature, “Practitioners tasked with the rehabilitation of 
forensic mental health patients commonly face formidable challenges” (Barnao & 
Ward, 2015, p. 77). This patient group, referred to as mentally disordered offenders 
(MDOs), typically presents with complex and chronic mental health difficulties 
(Palijan, Radeljak, Kovac, & Kovacevic, 2010), cognitive deficits (Fioravanti, 
Bianchi, & Cinti, 2012), and severe trauma (often involving maltreatment during 
childhood) (Spitzer, Chevalier, Gillner, Freyberger, & Barnow, 2006) in addition to 
having committed serious offenses which tend to be of a violent or sexual nature 
(Rutherford & Duggan, 2008). They tend to come from psychosocially deprived 
backgrounds which have often involved being in care or having multiple changes of 
caregivers, and have a history of substance abuse, poor education, unemployment 
and contact with psychiatric and criminal justice services (Völlm et al., 2017). This 
means that these individuals have a plethora of treatment needs relating to their 
mental health difficulties as well as their offending behavior (The Forensic Network, 
2012).  
 
In addition to the challenges posed by the patient group itself, the practitioner is 
faced with a lack of evidence-based interventions and theoretical rehabilitation 
models applicable to this patient group (Blackburn, 2004; Duncan, Nicol, Ager, and 
Dalgleish, 2006; Robertson, Barnao, & Ward, 2011; Barnao & Ward, 2015; Völlm et 
al., 2017). Though there has been increase in research on interventions developed for 
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the forensic services and on how interventions developed for the non-forensic 
population generalise to this patient group, it is not yet possible to reach any 
conclusions due to the fact that the majority of these studies have been small scale 
and of varying quality (Duncan et al., 2006).  
 
The lack of a coherent treatment model could be explained by the fact that the 
forensic services have their roots in two different systems: the mental health services 
and the criminal justice system; these approaches have different emphases as the 
psychopathology paradigm focuses on the treatment of mental illness whilst the risk 
paradigm focuses on assessing and managing the risk of re-offending (Robertson et 
al., 2011). To target the treatment needs required by both these paradigms, blended 
treatment programs addressing both mental health difficulties and crimogenic needs 
are typically implemented (Vandevelde et al., 2017). However, this “hybrid” 
treatment approach could be problematic as these systems can have contrasting 
priorities and ethical values as practitioners working within mental health typically 
value individual wellbeing and autonomy whilst practitioners working within 
correctional services would typically value justice and public protection. In the 
absence of guidance on what issues should be targeted or what focus should be 
prioritised, the inconsistent care approach might mean that practitioners emphasizing 
mental health needs in their clinical practice may be criticized for neglecting 
criminogenic needs (e.g. Maden, Williams, Stephen,Wong, & Leis, 2004) whilst 
practitioners focusing mainly on risk management might be blamed for failing to 
fulfill the central role in forensic mental health services: to provide both care and 
treatment (e.g. Lindqvist & Skipworth, 2000) (Barnao & Ward, 2015).  
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1.2. Recovery and Quality of Life in forensic mental health  
 
However, it can be argued that this focus on deficits and problems fails to take into 
account the value of developing and enhancing the individual’s existing skills. 
During the last 20 years, an interest in individual potential and resilience has 
developed within research on mental wellbeing. This is reflected in the recovery 
model of mental illness, which proposes that mental health services should aim to 
increase an individual’s potential for growth despite residual symptoms (Ferguson, 
Conway, Endersby, & MacLeod, 2009). One of the most cited definitions describes 
recovery as “a deeply personal, unique process of changing one’s attitudes, values, 
feelings, goals, skills and/or roles. It is a way of living a satisfying, hopeful, and 
contributing life, even with limitations caused by illness. Recovery involves the 
development of new meaning and purpose in one’s life as one grows beyond the 
catastrophic effects of mental illness” (Anthony, 1993, p. 527). Due to a growing 
consumer-led movement, the traditionally pessimistic view of schizophrenia in terms 
of prognosis and quality of life has been challenged; the alternative conceptualisation 
of the condition has been supported scientifically as long-term studies have found 
that as high as 50 per cent of individuals with schizophrenia have good outcomes 
(Bellack, 2006).  
 
This more holistic approach in terms of mental health and recovery has created a 
focus on Quality of Life (QoL) (Connell, O'Cathain, & Brazier, 2014). Though this 
is a difficult construct to define, it is typically described “as individuals’ perception 
of their position in life in the context of the culture and value systems in which they 
live and in relation to their goals, expectations, standards, and concerns” (World 
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Health Organisation (WHO), 1995, p. 1405). A less formal definition of QoL has 
been suggested by Lehman (1996): “…patients’ perspectives on what they have, 
how they are doing, and how they feel about their life circumstances. At a minimum, 
QoL covers persons’ sense of well-being…” (Lehman, 1996, p. 78). Though there is 
no overall definition of what QoL should include, it is widely agreed within the field 
that QoL should cover the individual’s evaluation of their life in terms of their: 
physical state; their psychological functioning (i.e. cognitive and affective state); and 
their social life (i.e. interpersonal relationships and social roles) (Basu, 2004). This 
conceptualisation of QoL seems to be reflected in terms of outcome measures, a 
review (Van Nieuwenhuizen et al., 2011) found that the most commonly assessed 
domains when measuring QoL for people with severe mental illness included health, 
employment or work, leisure, living situation, and relationships. The 
conceptualisation mentioned above also maps neatly onto what service users have 
identified as the most important aspects of QoL and recovery for them (i.e. well-
being and ill-being; relationships and a sense of belonging; activity; self-perception; 
autonomy, hope and hopelessness; and physical health) (Connell et al., 2014). 
Though there is a general consensus that QoL should be based on the patients’ 
perspective of their overall life, some researchers have argued that subjective 
evaluations may be compromised by other factors (e.g. medication, cognition, 
emotional functioning, and motivation for life improvement) (Basu, 2004). 
 
Though a focus on recovery has also been applied in forensic services, the process is 
more complex as it must also include recovery in terms of offending (Barnao & 
Ward, 2015). Despite this, QoL might have an important role to play in forensic 
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mental health services through its close links with both criminal behavior and 
psychological functioning; indeed, it is possible that a strength-based approach might 
reconcile the two existing paradigms in forensic services by transcending the focus 
on problems and limitations. As proposed in the General Strain Theory (Agnew, 
1992), crime might be understood as a consequence of how individuals who lack 
skills and resources are coping with conditions involving goal blockage, loss of 
positive stimuli, and/or the presentation of negative stimuli. The theory is similar to 
the concept of “Good Lives Model” (Ward, 2002), which proposes that maladaptive 
behaviour (including offending) diminishes when the person’s underlying needs 
(“primary goods”) are met (Bouman, Schene, & de Ruiter, 2009). These suggestions 
are supported empirically by research showing that certain objective indicators of 
QoL (e.g. adequate financial management, church attendance and work) as well as 
indicators of subjective QoL reduce re-offending (Bouman, de Ruiter, & Schene, 
2010). Improved QoL has also been found to predict reductions in recidivism whilst 
a meaningful life was found to be negatively related to recidivism in a sample of 
forensic psychiatric outpatients (Bouman et al.,  2009). In addition, unfulfilled 
primary goods have been found to be associated with unfavorable outcomes 
including mental health difficulties and offending (Barendregt, 2015). This illustrates 
the importance of targeting QoL in interventions for individuals in forensic services.  
 
2. Aims of the review 
 
This systematic review will focus on the efficacy of psychological interventions on 
QoL among mentally disordered offenders with psychotic disorders. The focus is 
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important from a scientific point of view as previous reviews have shown that there 
is a lack of evidence-based research (Laithwaite, 2010; Tapp, Perkins, Warren, Fife-
Schaw, & Moore, 2013; Slater & Townend, 2016) and clinical guidelines (National 
Health Service (NHS) Education for Scotland (NES), 2015); The Forensic Network, 
2012) for this patient group; this means psychosocial interventions for this patient 
group are routinely offered in forensic mental health settings despite the fact that 
little is known about necessary adaptations to this context or the treatment effects 
(Laithwaite et al., 2009). This is worrying considering that the majority (70%) of 
patients in secure forensic settings suffer from psychosis (Walker et al., 2013). 
Further research is also needed from a clinical point of view as NICE has 
recommended that psychological therapies should be offered in conjunction with 
medication to support recovery from psychosis (Attard & Larkin, 2016). This is 
important as a significant proportion of individuals with psychosis have a poor 
response to antipsychotic medication (Aust & Bradshaw, et al., 2017) and as 
outcomes are shown to improve when medication is combined with psychosocial 
interventions (Guo et al., 2010). As discussed above, a focus on QoL would, in 
addition to the value this would have for the individual, be of value for public 
protection due to its potential to reduce criminal behaviour. It is therefore hoped that 
a systematic review of the current literature will add to our current understanding of 
QoL among mentally disordered offenders with psychotic disorders to inform 
current practice and future research. 
 
Extensive reviews of the literature found two systematic reviews of relevance to this 
systematic review: Ross, Quayle, Newman, & Tansey (2013) and Geddes (2015). 
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Ross et al. (2013) found that 8 of the 10 studies that were included in their review on 
psychosocial interventions for violent behaviour in forensic and clinical settings led 
to reduced physical aggression. In a review by Geddes (2015) that focused on the 
efficacy of psychosocial interventions on psychotic symptoms, it was found that four 
of the included eight studies led to significant improvements in psychotic symptoms. 
However, as pointed out by both Ross et al. (2013) and Geddes (2015), the findings 
were limited by the heterogeneous nature of the included studies which made it 
difficult to identify differences between interventions and specific populations that 
would be likely to benefit from these. Both the studies were of importance as they 
had a similar design due to the review question and participant population. This 
review will therefore expand on these previous reviews to address gaps in the 
evidence base by focusing on the impact of psychosocial interventions on QoL for 




The Population, Intervention, Comparison and Outcome (PICO) (Booth & Fry-
Smith, 2003) parameters were used to formulate the research question and to 
facilitate the search strategy (Tapp et al., 2013). The acronym was modified to 
PICOCS to reflect the importance of the Context and to describe the rationale for the 
Study design as suggested in the Centre for Research and Dissertation’s (CRD) 
guidelines for undertaking reviews in health care (University of York, 2008).  
3.1. Population 
 
Studies focusing on a forensic adult (over 16 years old) population with a psychotic 
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disorder (as defined by a stated diagnosis of schizophrenia, schizoaffective disorder, 
delusional disorder, bipolar affective disorder, psychotic depression or atypical 
psychosis) were included. Forensic patients were defined as in the Forensic Matrix: 
“forensic patients are considered to include adults who are subject to compulsory 
measures under mental health legislation and who present a significant risk to 
others, such that they require care under conditions of security and/or specialist 




Studies were included if they used any form of psychological intervention that 




All types of controlled trials and cohort studies were included. Case series (both with 
small numbers and single cases) were excluded due to the likelihood of bias due to 
limited participant numbers and issues around generalising results. 
 
3.4. Outcome measures 
 
Included studies had to apply psychometric self-rated outcome measures that 
reported on aspects of QoL. The current systematic review included studies that 
assessed either internal or external domains of QoL (either as a primary or a 
secondary outcome measure); this included self-esteem, quality of life, life 
satisfaction, and/or self-efficacy in relation to life-goals. Self-esteem was defined as 
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an individual’s overall evaluation of the self (Smith & Mackie, 2007). Quality of life 
was conceptualised as an individual’s perception of their position in life in relation to 
their goals and standards (WHO, 1995) whilst self-efficacy was defined as an 




Studies focusing on any type of forensic setting (i.e. both in-patient hospitals and 
community services) were included.    
 
3.6. Study design 
 
A narrative synthesis was chosen rather than a meta-analysis due to the 
heterogeneous nature of the included studies. Interventions were grouped according 
to research design and outcome measures.  
4. Literature search strategy  
 
4.1. Keywords  
 
A systematic review of peer-reviewed published literature was conducted between 
August and September 2017. The following online databases were included: 
PsycINFO (1806-present); Ovid Medline (including Ahead of Print; In-Process & 
Other Non-Indexed Citations and Daily) (1946-present); Embase (1974-present); and 
Web of Science (1900-present). In order to generate search terms, the author of this 
review discussed key terms from related reviews with the second and third authors of 
this review and used the thesaurus and 'map terms' functions within databases 
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drawing on the university librarian to modify and/or expand on these. The final 
search terms were schizophrenia OR schizophren* OR psychotic OR psychosis OR 
schizoaffective AND cognitive OR psychosocial OR psychological AND forensic 
OR security OR secure OR offender.  
 
4.2. Results and Prisma 
 
The search resulted in 2582 articles, which after removal of duplicates became 1984 
articles (see Figure 1). A further 1819 were excluded after reading the title and/or 
abstract. After reading 165 full-text articles, 45 studies were assessed for eligibility 
and 5 were classified as relevant. A further five articles were identified as they were 
referred to in the full-text articles. Of the 50 relevant articles, 10 were intervention 
studies that included quantitative measures on QoL and were hence included (see 












5. Assessment of quality of included studies 
 
The quality criteria used in the studies by Ross et al. (2013) and Geddes (2015) was 
used to assess the quality criteria of the included articles as they were developed for 
a similar design and were hence considered more appropriate than generic guidelines 
(e.g. National Institute for Health and Care Excellence (NICE), 2013). The criteria 
were based on CRD’s guidelines (University of York, 2008) which are accepted 
internationally for conducting systematic reviews in healthcare settings; these 
propose that the following aspects should be evaluated: study design; bias; study 
quality; outcome measures; statistical analysis; quality of reporting; quality of 
intervention; and generalisability.  
 
Twelve quality criteria were used to assess the papers, with the outcomes scored as: 
well covered (3); adequately addressed (2); poorly addressed (1); or not addressed, 
reported, or applicable (0) (see Appendix B for full criteria). A strength of this 
approach is that it was used in previous research and developed for this specific type 
of research and population, whilst a limitation of the quality criteria was that equal 
weights were assigned to all aspects and that it treated all types of studies (i.e. RCT 
and cohort studies) equally. A second rater (E.E.) assessed 5 articles (50% of the 
sample) to measure inter-rater reliability; a Kappa co-efficient for overall agreement 
of 0.75 was found which indicates adequate inter-rate agreement (Randolph, 2008). 
Differences between markers were discussed and amended when appropriate.  As the 
quality criteria were applied to four of the ten included studies in a previous review 
(Geddes, 2015), these articles were rated and then compared against the previous 
ratings. No differences between the ratings were found. 
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6. Results  
 
6.1. Characteristics of included studies 
 
The included studies are summarised in Table 1. Two were randomised controlled 
(RCT) studies (Aho-Mustonen et al., 2011; Walker et al., 2013) whilst eight were 
cohort (pre-post) designs (Ferguson et al., 2009; Jennings et al. 2002; Laithwaite et 
al., 2007; Laithwaite et al., 2009; Livingston, Nijdam-Jones, Lapsley, Calderwood, 
& Brink, 2013; Long, Banyard, & Dolley, 2016; McInnis, Sellwood, Jones, 2006; 
Vallentine, Tapp, Dudley, Wilson, & Moore, 2010). Most studies focused on male 
participants (N= 9) in high security settings (N=6) in England (N=5) or Scotland 
(N=3) with other studies taking place in Finland (N=1) and Canada (N=1). The most 
commonly measured construct in the studies was self-esteem (N=7), where the 
majority of these studies used the Rosenberg Self-esteem Scale (RSE) (Rosenberg, 
1965) (N=4). Other measurements included quality of life (N=2); self-efficacy 
(N=2); and satisfaction with life (N=1). All interventions were delivered in a group 
format and based on Cognitive Behaviour Therapy (CBT) principles.  
 
6.2. Summary of results- the impact of psychosocial intervention on 
increasing Quality of Life 
 
The results are divided into sections depending on the outcome measures used: the 
most commonly used measure of self-esteem, RSE, or other measures.  
 
6.2.1. Studies using Rosenberg Self-esteem Scale (RSE) (Rosenberg, 1965) 
 
In a RCT by Aho-Mustonen et al. (2011), psychoeducation was compared to 
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treatment as usual (TAU) at a psychiatric hospital for forensic, difficult-to-treat 
and/or dangerous patients with mental disorders in Finland. The study found that the 
intervention led to significant improvements on self-esteem (as measured with RSE) 
when compared to the TAU group when administered to forensic patients post 
intervention (p= .03); however this effect was not maintained at follow-up three 
months later (p= .06). Interestingly, significant (no p-values reported) improvements 
on quality of life (as measured with Sintonen’s (2001) 15D instrument) were found 
for the control group at follow-up when comparing this to the control group’s 
baseline but not when comparing the different groups at post intervention (p= .50) or 
follow-up (p= 0.09) ; the authors of the articles suggested that the control group’s 
improvements  might be due to the control group receiving more attention than usual 
but without the potentially negative effect of increased insight on quality of life that 
might have taken place as a consequence of the intervention. This study was the 
study with highest quality of the included studies due to being a well-designed RCT. 
It was also the intervention that led to the largest effect size as a medium to large 
effect size (Cohen’s d= .71) was found on RSE. The study’s main limitation was that 
no power calculation had been reported. Also, the intervention was only described to 
a limited extent meaning the study did not contain enough information to be 
replicated. As the intervention was based on Ascher-Svanum & Krause’s 
Psychoeducational Groups for Patients with Schizophrenia from 1991, it is possible 
that the psychoeducation would have benefited from being updated considering the 
improved understanding of the condition that has been established since then (e.g. in 




In a study by Jennings et al. 2002, the effect of a psycho-educational programme in a 
high security setting was evaluated. The study found that self-esteem did not 
improve following the intervention as the mean on RSE prior to the intervention was 
23.57 compared to 23.28 following the intervention. Although this increased to 
27.43 at the six-month follow-up, it was found that the intervention did not lead to 
any significant improvements post intervention (Cohen’s d=.12) (no p-values 
reported). It was hypothesised that RSE might be a rather crude measure which may 
not have been sensitive enough to detect minor changes. This does not seem to be 
supported as other studies (e.g. Aho-Mustonen et al. 2011) included in the review 
found differences on this measurement.  
 
Laithwaite et al. (2007) applied an intervention (previously evaluated in a non-
forensic population) developed to improve self-esteem to offenders in a high-
security setting in Scotland. Significant improvements were found on the RSE (p 
<.05) and the Self-image Profile for Adults (SIP-AD) (Butler & Gasson, 2004) (p 
<.01) following the intervention which was still significant at follow-up three 
months later for RSE (p <.05) but not on the SIP-AD. No differences were found on 
the third measure (The Robson Self-Concept Questionnaire (RSCQ) (Robson, 1989)) 
(p = .20). The authors thought that the lack of effect on the RSCQ might be due to 
the RSCQ tapping into particular aspects of self-esteem that were not targeted by the 
programme or due to the measure not being validated for a forensic population. As 
each session lasted for 2 hours 30 minutes, it is remarkable that subjects (N=15) 




In a subsequent study by Laithwaite et al., (2009) on the same study population, a 
compassionate mind training (CMT) group intervention was evaluated. It was argued 
that CMT was needed as many patients taking part in the self-esteem programme 
described above were able to challenge their self-critical thinking style on an 
intellectual level but continued to feel worthless; this suggests that processes in 
relation to self-compassion and self-soothing might need to be addressed to create a 
positive self-image on an affective level. It was found that the intervention led to 
significant changes on the RSE when comparing baseline and follow-up (p >.01) but 
not post intervention (no p-values reported) but that no changes were found on the 
SIP-AD (p = .566) or the RSCQ (p =.603); the reasons for the differences between 
the self-esteem measures were not discussed but might be the same as in the 
previous study (i.e. outcomes tapping into different constructs of self-esteem). The 
quality of the study was high as most essential parts (with the exception of power) 
were addressed. However, the CMT did not have a strong effect on self-esteem as 
effect sizes were found to be .14 (Cohen’s d) on RSE which is below the threshold 
for a small effect.       
 
6.2.2. Alternative measures 
 
Ferguson et al. (2009) piloted an intervention aimed at increasing QoL among other 
variables by developing goal setting and planning skills in forensic settings in the 
London area; the intervention has been applied before to individuals with affective 
disorders in a non-forensic setting with promising results (MacLeod, Coates, & 
Hetherton, 2008). In the current study, significant improvements (p <.05) were found 
on satisfaction with life (as measured with the Satisfaction with Life Scale (SWLS) 
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(Diener, Emmons, Larsen & Griffen, 1985) at follow-up but not post intervention (p-
values not reported). Though it was stated that the format of the intervention was 
tailored to the population (e.g. more sessions, simplified language), the study could 
have been improved by considering how the content of the intervention could have 
been adapted for the forensic population (e.g. whether the process of establishing 
goals was affected by the constraints posed by being cared for in a forensic setting). 
This was the only study where a researcher would meet with the participant to cover 
session material on occasions they were unable to attend a session; this was a 
strength of this research.  
 
Livingston et al. (2013) conducted a naturalistic longitudinal study in Canada that 
looked at the effect of an intervention (that included a peer support programme, a 
patient advisory committee, and a patient research team) on, among other 
measurements, empowerment (which included self-esteem and self-efficacy) as 
measured by the Making Decisions Empowerment Scale (MDES) (Rogers, 
Chamberlin, Ellison, & Crean, 1997). It was found, when evaluated after nine 
months, that taking part in the overall intervention did not led to significant 
differences (p >.05) which was suggested to be due the fact that the study did not 
have enough power for detecting small to medium effects. A particular strength of 
the study was the inclusion of a power calculation, a qualitative approach being 
added to the quantitative measures which included patients’ view of the service 
development, and the observations of staffs’ reluctance to engage with a recovery-
oriented care approach. The unusual design makes it difficult to compare it to the 
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other studies in terms of quality as the study was a process evaluation rather than a 
theoretically driven intervention.  
 
In one of the few studies evaluating interventions for female offenders with 
psychotic disorders, Long et al. (2016) administered a psychoeducation programme 
(the Living with Mental Illness Programme) that was specifically tailored for female 
offenders at a Women’s Service at a secure psychiatric hospital in England. The 
intervention was found to lead to significant improvements (p <.01) on a self-
efficacy measurement (Generalized self-efficacy (GSES)) (Jerusalem & Schwarzer, 
1992) for completers but not for non-completers following the intervention. Due to 
its focus on female offenders, this study differed from the other included studies by 
addressing an obvious gap in the literature which represents a strength. A significant 
limitation is the lack of power calculation, baseline data for this specific measure, 
and follow-up.   
 
In a study by McInnis et al. (2006), it was found that a group based educational 
programme did not lead to any improvements (no p-values reported) on self-esteem 
(as measured by the Culture Free Self Esteem Inventory 2nd edition (CFSE-II) 
(Battle, 1992)) in a sample of male offenders. This might be explained by the fact 
that the measure contained a subscale relating to social self-esteem (i.e. perception of 
quality of relationship with peers) which is likely to be affected by being cared for in 
a forensic setting where the patient has not chosen his or her social network. In 
similarity to many of the other included studies, the study lacked means and standard 
deviations, power calculations, and a sufficient description of the intervention. A 
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strength of the intervention was how the multidisciplinary team and other 
contributors contributed to sessions (e.g. drama therapist in a session on 
assertiveness, voluntary organisation providing community work placements in a 
session on negative symptoms).    
 
Finally, in a study by Vallentine (2010), psychoeducation was provided to 31 
mentally disordered offenders in a high security hospital in London where indices of 
clinical and reliable significant change were calculated in addition to aggregated 
means analysis (t-tests). Self-esteem was measured with RSCQ; this was found to 
result in a clinical change for two subjects and a reliable change for five subjects. 
The alternative analysis applied in the study adds to the interpretation of the data as 
no significant changes were found (p-values not reported) when applying paired 
sample t-tests to pre and post intervention scores on the RSCQ. A limitation is that 
no information except the title of the intervention was included. As no significant 
change was found on the RSCQ in similarity to Laithwaite et al. (2007) and 
Laithwaite et al. (2009), it is possible that this measurement might not be sensitive 
enough for measuring changes in self-esteem over time in a forensic population.  
 
Walker et al.’s (2013) study compared psychoeducation to TAU in a RCT across 
four sites of various levels of security in Scotland. In contrast to the study by Aho-
Mustonen et al. (2011), this study evaluated a psychoeducational programme 
(Coping with Mental Illness) that was explicitly created for psychosis in a forensic 
setting, making it more relevant for the patient group. It was found that the 
intervention did not lead to significant improvements on quality of life (as measured 
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by the Schizophrenia Quality of Life Scale Revision 4 (SQLS-R4) (Martin & Allan, 
2007) post intervention (p = .47). However, as it was found though that the measure 
was significantly affected by level of intelligence (as measured by the Wechsler 
Abbreviated Scale of Intelligence (WASI) (Wechsler, 1991)), the validity and the 
reliability of the measure are questioned (Nishiyama & Ozaki, 2010). The most 
significant limitation of the study was that it was underpowered due to issues of 
random allocation (i.e. all subjects had been allocated to the treatment group on 
instructions from the line management). It could also be suggested that the patient 
group was rather heterogeneous considering that they were recruited from one high 
security, two medium security and one low security setting and included patients 
with schizophrenia, schizotypal, delusional disorders, and mood disorders as well as 
mental and behavioural disorders due to substance abuse. As no baseline data was 
reported, it was not possible to calculate effect sizes. In addition, the study would 
have been of higher quality if the validity and reliability of the outcome measures 
had been reported.   
 
6.3. Summary across all studies 
 
There were 271 participants in total across all the studies. Of the ten included 
studies, half of these (Aho-Mustonen et al., 2011; Ferguson et al., 2009; Laithwaite 
et al., 2007; Laithwaite et al., 2009; Long et al., 2016) found that psychosocial 
interventions lead to significant improvements on QoL either post intervention or at 
follow-up despite different designs, length of follow-up periods, and outcome 
measures whilst half did not find any significant differences (Jennings et al., 2002; 
Walker et al., 2013; Livingston et al., 2013; Vallentine et al., 2010).  
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The improvements were suggested to be due to participants developing rational 
(Laithwaite et al., 2007) or compassionate (Laithwaite et al., 2009) alternatives to 
self-critical thoughts which might lead to improvements in mood (Laithwaite et al., 
2007). It was also proposed that QoL improved due to the development of goal 
mastery that allowed patients to work towards desired “primary goods” (e.g. 
intimacy, knowledge, mastery) in accordance with the Good Lives Model (Ferguson 
et al., 2009). A further potential explanation was that improvements were due to a 
sense of empowerment through subjects accessing knowledge about their illness 
(Vallentine et al., 2010; Long et al., 2016) or increased service involvement 
(Livingston et al., 2013). The effect sizes between pre and post intervention varied 
from non-existent (Jennings et al., 2002; Laithwaite et al., 2009; Livingston et al., 
2013; Vallentine et al., 2010) to small (Ferguson et al., 2009) to medium (Aho-
Mustonen et al., 2011; Laithwaite et al., 2007). As all findings were based on small 
sample sizes, it is difficult to generalise findings to the wider forensic population. 
 
6.4. Quality of included studies 
 
Table 2 provides quality ratings for each of the ten studies. It was found that the both 
the RCTs (Aho-Mustonen et al., 2011; Walker et al., 2013) were of highest quality 
which could be explained by the superiority of their design (e.g. inclusion of control 
group) which gave them high scores on variables (i.e. randomisation and 
concealment) that cohort studies would not have been given. The earliest study 
(Jennings et al., 2002) received the lowest quality ratings due to lack of statistical 
analysis. Overall, the most common quality issues were not reporting validity and 
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reliability of the measurements; not including power calculations; not using standard 



















Main findings for quality of life, 
self-esteem, self-efficacy in relation 
to life goals, or life satisfaction 
Effect size 
Cohen’s 













Mixed RCT High  Psycho-
education 
 







Self-esteem was significantly 
improved compared to TAU post 
intervention (p= .03) which was not 
maintained at follow-up 3 months 
later (p= .06) whilst the intervention 
had no impact on quality of life post 























Life satisfaction was significantly 
higher at follow-up 2 months later (p  
<.05) but not post intervention (p-

































Self-esteem did not improve 
following the intervention as the 
mean on RSE prior to the 
intervention was 23.57 compared to 
23.28 following the intervention. 
However, this increased to 27.43 at 
the six-month follow-up. No 

























Significant improvements were 
found on RSE post intervention  
(p <.05) and at follow-up (p <.05) 
and on the SIP-AD post intervention 
(p <.01) but not at follow-up (p-






















Main findings for quality of life, 
self-esteem, self-efficacy in relation 
to life goals, or life satisfaction 
Effect size 
Cohen’s 
d, pre vs 
post 
  time were found on the RSCQ  



















Significant improvements were not 
found at the RSE post intervention 
(p-value not reported) but were 
found at follow-up (p <.01). No 
significant effects were found at 
RSCQ (p = .603) or the SIP-AD  






































No significant differences were 
found between patients’ scores on 




























A significant increase at the GSES 
was found for completers compared 
to non-completers (p <.01) following 


















 n/a CFSE-II- 
self-esteem 
 
No significant differences post 













 n/a SCQ- self-
esteem 
No significant differences were 


















Main findings for quality of life, 
self-esteem, self-efficacy in relation 
to life goals, or life satisfaction 
Effect size 
Cohen’s 











































No significant (p = .47) differences 
between TAU and intervention were 
found on quality of life as measured 
by the SQLS-R4 (follow-up data 







Measures: RSE: Rosenberg Self-esteem; SWLS- Satisfaction with Life Scale; RSCQ- The Robson Self-Concept Questionnaire; SIP-AD The Self-Image Profile for 
Adults; MDES- Making Decisions Empowerment Scale; GSES- Generalized Self-efficacy; CFSE-II -Culture Free Self Esteem Inventory (2nd edition); CORE-


































AA WC WC AA WC NA WC WC WC WC WC AA 30 
Ferguson 
et al 2009 
NA NA WC AA WC WC WC AA AA AA WC AA 25 
Jennings 
2002 
NA NA WC PA WC NA NA PA AA AA WC WC 18 
Laithwaite 
et al 2007 
NA NA WC PA WC NA WC AA WC AA WC AA 22 
Laithwaite 
et al 2009 
NA NA WC PA WC NA WC AA WC WC WC WC 24 
Livingston 
et al 2013 
NA NA NA WC WC WC WC AA PA AA WC NA 20 
Long et al 
2016 
NA NA PA WC WC WC AA WC WC AA WC NA 22 
McInnis et 
al 2006 
NA NA NA WC WC NA AA AA AA AA WC AA 19 
Vallentine 
et al 2010 
NA NA PA AA WC NA AA AA AA WC WC AA 20 
Walker at 
al 2013 
WC AA WC PA WC NA WC WC AA PA WC WC 27 
 






7.1. Overall findings  
 
This systematic review aimed to synthesise and critically appraise the available 
evidence base on the effectiveness of psychosocial interventions on QoL in adults 
with psychotic disorders in forensic settings. Quality of Life in forensic services 
represents an under-researched but important research topic given the emphasis on 
recovery in mental health (Ferguson et al., 2009). Five of the ten included studies 
(i.e. Aho-Mustonen et al., 2011; Ferguson et al., 2009; Laithwaite et al., 2007; 
Laithwaite et al., 2009; Long et al., 2016) found that psychosocial interventions led 
to improvements on QoL either at post-intervention or at follow-up. Whilst these 
findings were encouraging, the heterogeneity and the quality of the included studies 
prevented any firm conclusions. 
 
7.2. Discussion of findings  
 
In the study (McInnis et al., 2006) that did not find any improvements, the lack of 
effect on self-esteem was suggested to be due to in-session material which 
encouraged patients to reflect on difficulties with previous community placements 
and to problem-solve future difficulties with community living; it was hypothesised 
that this might have led to doubts in relation to patients’ perceptions of their ability. 
This is similar to the suggestions made by Jennings et al. (2002) as they 
hypothesised that the intervention’s focus on increasing individuals’ awareness of 
their ability to exert control over their behaviour might have led to a greater sense of 
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responsibility for their past offences and consequently more negative self-
perceptions initially. Both these suggestions seem to suggest that improvements in 
insight might have a negative impact on self-esteem. Paradoxically, insight has been 
linked with both lower self-esteem and better functioning in previous research. These 
contradictory findings might be due to a third confounding variable: the degree 
which to which an individual internalises stigma in relation to mental illness. It has 
been found that persons with high insight who internalised stigma had lower self-
esteem and hope than those with high insight who did not internalise stigma and 
those with low insight who did internalise stigma (Lysaker, Roe, & Yanos, 2006). 
The relationship between the variables is further supported by the fact that 
internalised stigma was found to moderate the relationship between insight and low 
self-esteem/quality of life (Staring, Van der Gaag, Van den Berge, Duivenvoorden & 
Mulder, 2009). It has therefore been recommended that psychosocial interventions in 
schizophrenia should incorporate information on stigma and quality of life issues. It 
was encouraging to find that this recommendation was followed by all the 
interventions discussed in this systematic review.  
 
As most of the interventions focused on providing psychoeducation in relation to 
mental health (Aho-Mustonen et al., 2011; Jennings et al., 2002; Long et al., 2016; 
McInnis et al., 2006; Vallentine et al., 2010; Walker et al., 2013), the results indicate 
that this might be a effective approach to improve QoL in forensic settings despite, 
as suggested by Barnao & Ward (2015), its focus on deficits. Similar findings have 
also been found in non-forensic settings, where psychoeducational interventions 
have been found to lead to improvements on QoL (e.g. Knight, Wykes, & Hayward, 
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2006; McCoy et al., 2006; Fung, Tsang, & Cheung, 2007; Sauvanaud et al., 2017). 
This might be due to the participants feeling empowered by being trusted with this 
information and self-care tools by the practitioners, which might make participants 
feel that they are not just passive recipients of treatment (Walker et al., 2013). It 
could also be due to the psychoeducation limiting the degree of internalised stigma, 
which, as discussed above, should have a positive impact on QoL. Additionally, the 
improvements in QoL might be due to most psychoeducational programmes for 
mental health difficulties currently used in forensic settings (e.g. Road to Recovery) 
are applying a strength-based approach. This might suggest that a shift from focusing 
on deficits to strengths has already been observed in forensic services (Vandevelde et 
al., 2017) and that implementing new ways of working (e.g. Good Lives Model) 
might in fact not be needed. It is interesting that Scottish Intercollegiate Guidelines 
Network (SIGN) advise against offering psychoeducation as a stand-alone treatment 
for schizophrenia (SIGN, 2013). This might be due to the focus on symptoms and 
behavior rather than QoL when reviewing the existing evidence base.    
 
As all of the studies were based on principles of CBT, the review suggests that there 
is evidence for the effectiveness of this on self-esteem, quality of life, life 
satisfaction, and/or self-efficacy in forensic settings. However, it is difficult to draw 
firm conclusions on effective mechanisms for change due to the different forms and 
treatment focuses of CBT used in the studies (i.e. psychoeducation; compassionate 
mind training; self-esteem programme; goal setting and planning training). Further 
research identifying mechanisms of change is therefore required. This should ideally 
also address other aspects of the provision of therapeutic interventions that differ 
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between the studies and which could have an impact on the outcome (e.g. dosage, 
group or individual, level of training of the providers, supervision arrangements). 
 
7.3. Limitations of the findings and areas for future research 
 
It is also important to acknowledge that there was heterogeneity between the studies 
in terms of patients as some studies included subjects who, in addition to a primary 
diagnosis of a psychotic illness, also had emotionally unstable personality disorders 
(Long et al., 2016; MacInnes et al., 2006) or anti-social personality disorders 
(Laithwaite et al., 2007; Laithwaite et al., 2009). This is important as the presence of 
a diagnosis of emotionally unstable personality disorder was linked with poor 
attendance in the study by McInnis et al. (2006); it was suggested this was due to 
difficulties with group interactions or including women with a history of sexual 
abuse in settings with mainly men. (It should be noted though that the participants 
struggled with attending a psychoeducational group in the study by Long et al. 
(2016) despite being delivered in a women’s only service). Differences between 
studies were found on inclusion and exclusion criteria for psychotic disorders too as 
Aho-Mustonen et al. (2011) excluded patients with delusional disorders, which most 
other studies did not. The variations between study populations make it difficult to 
identify for whom psychosocial interventions would be most suitable for. Further 
research would therefore be needed to disentangle this.   
 
In addition, it is difficult to generalise findings due to the different measures used to 
measure QoL. This might reflect a wider confusion in the literature in relation to 
QoL (Camfield & Skevinton, 2008). The most commonly used measurement in this 
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study was found to be the Rosenberg Self-esteem Scale. Though an acceptable level 
of internal consistency for the scale was established in the study by Aho-Mustonen et 
al. (2011), the factor structure of the scale has been questioned elsewhere (see Huang 
& Dong, 2012 for a review). As none of the tests were validated on a forensic 
population, it is possible that the conclusions found in the studies may be affected by 
unnecessary measurement bias. This is a shame as a validated measure of QoL for 
the forensic population has been developed: the Forensic inpatient Quality of Life 
questionnaire (FQL) (Vorstenbosch, Bouman, Braun, & Bulten, 2014). It is 
recommended that this, or another validated measure, is used in future research.  
 
Finally, the findings are difficult to generalise as populations at different levels of 
security were used. Once a stronger evidence base for psychosocial interventions has 
been developed a further systematic review, or a meta-analysis would be 
recommendable to identify what interventions are most effective in high, medium, 
and low security settings. Further studies could have been included in this review if 
grey literature had been included as previously done in a systematic review by Slater 
& Townend (2016) where CBT for psychotic disorders in high security settings was 
evaluated in the peer-reviewed and fugitive literature. However, this review only 
focused on material that had been peer reviewed as the quality of the material in the 
grey literature cannot be guaranteed which would reduce confidence in any findings.   
 
An important issue raised in the study by Livingston et al. (2013) was the 
observation that forensic staff was reluctant to engage with the recovery-oriented 
care approach. This highlights an important aspect of implementing interventions 
that promote power sharing in forensic services: it may be perceived as risky 
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(Livingston et al., 2013). It is possible that restrictive practices are preferred at the 
expense of recovery-promoting practices due to the anxiety professionals feel over 
the consequences of underestimating an individual’s actual risk and in their duty of 
public protection (Mann, Matias, & Allen, 2014).  There might also be a 
psychological element to the findings in the study by Livingston et al. (2013) as 
summarised by Mann et al. (2014), “staff may find it difficult to share power with 
people guilty of violent crimes. Slade (2009a) highlighted the importance of an equal 
partnership in supporting a recovery focus, but staff may struggle to accept that they 
are equal to their patients, as this would mean they need to acknowledge there is 
nothing distinctly different between them and people who have committed serious 
crimes, thereby forcing them to face the ‘evil’ in all of us. It is far easier for staff to 
create a divide between themselves and those that commit such crimes” (Mann et al., 
2014, p. 128). The concept of recovery must therefore, in similarity to the mental 
health interventions promoting it, need to be modified to fit into forensic services. 
Further research on the empirical implementation of recovery in forensic services 
would therefore be essential.  
 
Finally, it is also possible that the conceptualisation of QoL had an impact on the 
results of the review as only studies that included self-reported measures of self-
esteem, quality of life, life satisfaction, and/or self-efficacy in relation to life-goals 
were included. Future literature reviews could extend on the current review by 
focusing on research that also includes objective measures of QoL as the validity of 
self-reported measures depend on the individual’s ability to reflect on his or her 
situation. This might be important as some research has found that self-reported QoL 
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is compromised by cognitive difficulties in patients with serious mental illness 
(Nishiyama & Ozaki, 2010) but not all research (Baumstarck et al., 2013).  
 
7.4. Strengths and limitations of this review 
 
This review extends findings from previous reviews in this area (Ross et al., 2013; 
Geddes 2015) by focusing on QoL as an outcome of psychosocial interventions in 
forensic settings. As such, it adds to the evidence base for implementing 
interventions with alternative focuses to violence reduction and psychotic symptoms 
in forensic settings. This is important for incorporating a recovery-focused care 
approach into forensic services. The systematic and extensive search strategy in this 
review represents a strength. Subjective bias was accounted for when assessing the 
quality of the papers by involving a second marker, which produced a higher degree 
of inter-rater reliability. The most significant limitation is the heterogeneity of the 
included studies, which limits the conclusions that can be drawn and does not allow 
a meta-analysis.   
 
7.5. Implications for further research 
 
Further research should explore the impact of being a forensic patient on QoL as 
well as how to improve QoL in the forensic population and factors affecting the 
outcomes. In addition, it would be desirable to use validated measures of QoL in 
future research. It would also be useful to include measures of QoL into standard 
research as the majority (>80%) of the intervention studies initially found in this 
systematic review did not measure this important construct.    
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7.6. Implications for clinical practice 
 
Despite previously mentioned limitations, the evidence found in this review supports 
the delivery of psychosocial interventions in forensic settings, as they are likely to 
increase QoL. To overcome the heterogeneity of the studies found in this review, 
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Metacognitive training (MCT) is an intervention designed for positive symptoms in 
schizophrenia that aims to improve insight into cognitive processes. The main author 
of this study created a modified version to address negative symptoms. The purpose 
of this study is to evaluate the feasibility of the modified version of MCT for 
negative symptoms. The quantitative approach was supplemented with qualitative 
interviews to incorporate participants’ views of the intervention. In addition, 
potential mechanisms of change were evaluated using a promising new method for 
analysing case-series: multilevel modeling. The intervention showed good feasibility 
as demonstrated by the attendance rate, the positive feedback from participants and 
the multidisciplinary team, and the improvements on negative symptoms that were 
found following the intervention. Multilevel modeling showed that depression, 
internalised stigma, and reflective functioning all explained the variance in negative 
symptoms. The pilot study indicated that the intervention has high feasibility and 
that improvements in negative symptoms can partially be explained by 
improvements on depression, stigma, and reflective functioning.   
 
Key messages for practitioners: 
 Negative symptoms can be improved with interventions targeting depression, 
internalised stigma, and reflective functioning 
 Metacognitive Training for Negative Symptoms may be an promising 
intervention to improve negative symptoms 






1.1. Negative symptoms in schizophrenia 
 
Negative symptoms in schizophrenia typically include blunted affect, alogia, 
asociality, avolition and anhedonia (Lincoln, Dollfus, & Lyne, 2017). Persistent 
negative symptoms are thought to be present in approximately 20-40% of the 
population with schizophrenia (Sarkar, Hillner, & Velligan, 2015). Factor analysis 
shows that the symptoms can be explained by two factors: diminished expression 
and amotivation (Elis, Caponigro, Kring, 2013). Risk factors for developing negative 
symptoms include being male, family history of psychosis, longer duration untreated 
psychosis (DUP), and lower premorbid functioning (McLeod, Gumley, MacBeth, 
Schwannauer, & Lysaker, 2014).  
 
Cognitive difficulties are unlikely to explain the development of negative symptoms 
as no relationship was found between PANSS negative factor (with the five-factor 
consensus model applied) and the MATRICS Consensus Battery (MCCB). It has 
been suggested that the small to moderate correlations found in earlier meta-analyses 
(e.g. Dibben, Rice, Laws, & McKenna, 2009; Dominguez, Viechtbauer, Simons, van 
Os, & Krabbendam, 2009; Ventura, Hellemann, Thames, Koellner, & Nuechterlein, 
2009) might have been due to confounding variables (e.g. substance abuse) or 
measurement overlap (e.g. the Scale for the Assessment of Negative Symptoms 
(SANS) (Andreasen, 1984); the Positive and Negative Syndrome Scale 




The symptoms are classified as secondary negative symptoms if they are thought to 
be due to medication, positive symptoms, depression, hypostimulating environments, 
or substance abuse; in contrast, primary negative, or deficit, symptoms refer to 
symptoms that are thought to be intrinsic to schizophrenia. There is a lack of 
research on secondary negative symptoms as most research on negative symptoms 
has focused on primary negative symptoms; this is problematic considering that 
secondary negative symptoms are more prevalent than primary negative symptoms 
as they occur in more than 50% of the population (Kirschner, Aleman, & Kaiser, 
2017). However, it has been questioned whether the distinction between primary and 
secondary symptoms remains valid as more than 80% of patients experience a 
depressive episode which suggests that depression might be something more than a 
co-morbid condition (Upthegrove, Marwaha, & Birchwood, 2017.  
 
Despite similarities in clinical presentation, there seems to be some differences 
between depression and negative symptoms as the concepts have been found 
orthogonal (Upthegrove et al., 2010). While both conditions seem to lead to deficits 
in anticipatory pleasure in terms of anhedonia, some features of anhedonia might be 
specific to subtype as consummatory pleasure seems preserved in negative 
symptoms but not in depression (Upthegrove et al., 2017). It has therefore been 
suggested that there might be three different pathways: depression which is intrinsic 
to the psychotic condition; depression as a psychological response to the diagnosis; 
and depression as well as psychosis as a consequence of childhood trauma, social 
adversity and neglect as these are established risk factors for mental health 
difficulties (Birchwood, Iqbal, & Upthegrove, 2005).    
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1.2. The cognitive model of negative symptoms in schizophrenia 
 
Negative symptoms can be conceptualised as a coping strategy that develops early in 
the psychosis, where shutting down of psychological systems allows the individual 
to cope with overwhelming or aversive situations; this leads to a reliance on negative 
symptoms (e.g. apathy, social isolation, and avolition) to reduce the impact of these 
experiences as well as the exposure to them (Beck, Rector, Stolar, & Grant, 2009). 
The avoidance and disengagement might be maintained by certain dysfunctional 
beliefs which could arise as a consequence of repeated failures and setbacks; these 
cognitions are suggested to include negative beliefs about social affiliations; low 
expectations of pleasure, success and acceptance; defeatist beliefs about 
performance; and a perception of limited resources (see Figure 1). Individuals 
diagnosed with schizophrenia may also incorporate stigmatising views of their 
mental illness into their self-construals, which will have a negative effect on their 
perceived self-efficacy. This may lead to a perception of not meeting self-imposed 
goals as well as feelings of guilt for failing to meet others’ expectations. It might be 






Figure 1. How negative expectancy appraisals could form negative symptoms. 
(Rector et al., 2005, p. 252) 
 
Research has shown that negative symptoms are found to be associated with low 
expectancies of success (Couture, Blanchard, & Bennett, 2011), asocial beliefs 
(Grant and Beck, 2010), a reduced sense of self-efficacy (Bentall et al., 2010), low 
self-esteem (Lincoln, Mehl, Kesting, & Rief, 2011), defeatist performance beliefs 
(Campellone, Sanchez, & Kring, 2016), and self-stigma (Horsselenberg, van 
Busschback, Aleman, & Pijnenborg, 2016). A longitudinal study has also found that 
low expectancy of success predicted future negative symptoms (Luther et al., 2016) 
whilst self-defeatist beliefs about performance were found to mediate the 
relationship between cognitive impairment and negative symptoms/functioning 
(Grant & Beck, 2009).  
 
Though not directly contradicting the cognitive model of negative symptoms, it is 
suggested that additional biological, cognitive, and psychosocial processes might be 
involved in the development and maintenance of negative symptoms as outlined in 
maintenance loop for negative symptoms (see Figure 2) (Velligan, Maples, Roberts, 
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& Medellin, 2014). According to this model, negative symptoms are proposed to be 
due to disruptions in different parts of the reward system, which might be due to a 
biological predisposition or secondary to treatment with dopamine antagonists. Once 
withdrawing behaviours are established, they are likely to be negatively reinforced 
due to the removal of distressing stimuli and the resulting feeling of temporary relief. 
Over time, the coping strategy leads to disruptions in everyday functioning and 
decreased quality of life due to a lack of positively reinforced experiences, resulting 
in atrophy of previously attained skills and the ability to plan for the future. The 
suggestion that the negative expectancies proposed by the cognitive model are due to 
deficits in the brain reward systems has been supported by the fact that subjects 
diagnosed with schizophrenia have been found to have lower scores on anticipatory 
pleasure compared to a control group whilst no differences in deriving pleasure 
(contrary to anhedonia) were found (Gard, Kring, Gard, Horan, & Green, 2007). 
 
Figure 2. The negative symptom maintenance loop. (Velligan et al., 2014, p. 5) 
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However, there is evidence that suggests negative symptoms might also be due to 
complex metacognitive processes as these have been found to predict negative 
symptoms after controlling for the cognitions suggested by Beck and colleagues 
(Lysaker et al., 2015). This suggests that metacognition, which is covered in the next 
section, might be an important factor in the development and maintenance of 
negative symptoms. 
 
1.3. The metacognitive model of negative symptoms in 
schizophrenia 
 
An additional, or potentially alternative, psychological factor for the aetiology of 
negative symptoms may be one’s metacognitive ability. Though metacognition 
initially referred to the capacity to think about and monitor one’s mental processes 
(Flavell, 1979), the definition has broadened in contemporary research to cover a 
range of mental processes from discrete acts (e.g. identifying cognitive biases) to 
more complex processes (e.g. deriving meaning from significant events) (McLeod et 
al., 2014). The ability to reflect on one’s mental states is also called mentalization or 
reflective functioning (Bateman & Fonagy, 2011) in the wider literature, though this 
does not include mastery (i.e. the ability to develop adaptive coping strategies based 
on one’s metacognitive understanding of the world). Mentalization also differs from 
metacognition as it views disruptions in reflectivity as only occurring in the context 
of disturbed attachment (Dimaggio & Lysaker, 2015). In this paper, the 
mentalization concepts defined by Lysaker, Bateman & Fonagy with colleagues will 




Metacognition as defined by Lysaker and colleagues is suggested to be relevant to 
negative symptoms as without a complex mental representation of one’s and others’ 
mental states, individuals would struggle to identify and express emotions or 
understand and value social interactions, making the individual less likely to 
experience rich emotions and volition (Lysaker et al., 2015). The suggestion that 
negative symptoms might be due to metacognitive deficits links in with earlier 
research that found schizophrenia is linked with difficulties identifying and 
understanding both one’s own and others’ mental states (Nicolo et al., 2012). The 
metacognitive model differs from the cognitive model as it proposes that it is the 
ability to engage in complex thought processes about oneself and others that will 
affect the richness of an individual’s ability to experience life and not just the 
particular beliefs discussed in the section above. This is more consistent with the 
original ideas by Bleuler (1911, 1950) that schizophrenia is caused by disturbances 
in associative processes which leave the individual unable to form complex ideas in 
order to sustain goal-directed behaviour. The relationship between negative 
symptoms and metacognition could also be due to other mechanisms such as 
attachment style or therapeutic alliance (Lysaker et al., 2015).  
 
Significant metacognitive deficits have been found in individuals diagnosed with 
schizophrenia relative to persons with bipolar disorder (Tas, Brown, Aydemir, 
Brüne, Lysaker, 2014); anxiety/depression (WeiMing, Yi, Lysaker, & Kai, 2015); 
prolonged medical conditions (Lysaker et al., 2014); PTSD (Lysaker et al., 2015); 
and substance abuse (Lysaker et al., 2014). A relationship between metacognition 
and negative symptoms is also supported empirically as severity of deficits in 
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metacognition has been linked to concurrent (Nicolo et al., 2012, Rabin et al., 2014), 
and prospective negative symptoms (Hamm et al., 2012). Metacognition was also 
found to predict negative symptoms in first episode psychosis (Mcleod et al., 2014). 
Interestingly, decentration (i.e. the ability to hold a non-egocentric perspective on 
others’ thoughts, motives, and desires) was found to be the subscale most strongly 
correlated with negative symptoms. This finding was suggested to be due to an 
increased self-focus combined with the patient’s belief that others are also focusing 
on them which may lead to difficulties to see events as unrelated to themselves. The 
results differs from the study by Nicolo et al. (2012) which found that negative 
symptoms were most strongly correlated to mastery; this is not surprising 
considering the fact that negative symptoms are argued to be a maladaptive coping 
strategy (Beck et al., 2009). Metacognition has also been found to predict negative 
symptoms in more chronic samples even after controlling for affect recognition, 
defeatist beliefs, and neurocognitive functioning (Lysaker et al., 2015). In a recent 
study (Weijers et al., 2018), mentalization was found to mediate the relationship 
between negative symptoms and reported childhood abuse which further supports the 
idea that negative symptoms may be a coping strategy of shutting down as a 
response to adversity.   
 
1.4. Psychological Interventions for negative symptoms 
  
1.4.1. Individual Studies 
 
Few studies have focused on psychological interventions developed to primarily 
target negative symptoms. In the first study (Daniels, 1998) that explicitly focused 
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on improving negative symptoms with Cognitive Behaviour Therapy (CBT), the 
approach was combined with group process strategies to create a social skills 
training programme (Interactive-Behavioural Training (IBT)). It was found that the 
intervention did not lead to an overall reduction on total and subscales scores on the 
Modified Scale for the Assessment of Negative Symptoms (SANS) (Woerner & 
Robinson, 1993). Improvements were also found for social functioning on the five 
outcome measures used in the study, though only the Global Assessment of 
Functioning Scale (GAF) (American Psychiatric Association (APA), 1994) was 
found to be significant. Though these findings are encouraging, they must be 
interpreted with some caution given the issues with the GAF of concurrent and 
predictive validity (see Aas, 2010).  
 
Klingberg et al., (2011) conducted a randomised controlled trial where CBT was 
compared to Cognitive Remediation Therapy (CRT). As no difference was found 
between the groups post-intervention on negative symptoms, the authors suggested 
that the effect could be due to both interventions helping patients to experience 
pleasure and success leading to an impact on negative symptoms. In a study by 
Grant, Huh, Perivoliotis, & Stolar (2012), which compared CBT that specifically 
targeted the dysfunctional beliefs suggested by Rector et al., (2005) to treatment as 
usual, significant improvements were found on functioning, apathy and avolition but 
not on anhedonia, flat affect and alogia. It should be acknowledged that a high (>50) 
number of sessions were offered which limits the feasibility of introducing the 
intervention in standard clinical practice. In an uncontrolled pilot study by Staring, 
Ter Huurne, van der Gaag (2013) that used the same approach but only offered 20 
77 
 
sessions, significant improvements were found on negative symptoms; the 
improvements were found to be partially mediated by a change in dysfunctional 
beliefs. However, as the study used the original subscale of negative symptoms 
rather than the suggested five-factor model (Wallwork, Fortgang, Hashimoto, 
Weinberger, & Dickinson, 2012) as the primary outcome, it is possible that the 
intervention had an impact on factors that would not necessarily be conceptualised as 
negative symptoms.   
 
MOtiVation and Enhancement (MOVE) Training (Velligan et al. 2014) was 
developed to improve initiation, success, enjoyment, and adaptive behaviours to 
target both the dimensions of negative symptoms (i.e. emotion expression and 
anhedonia/amotivation). In a randomised pilot study (Velligan et al., 2015) MOVE 
was compared to treatment as usual (TAU) for nine months. In contrast to other 
studies, the study included an impressive three measures of negative symptoms: the 
Negative Symptom Assessment (NSA-16) (Axelrod, Goldman, & Alphs, 1993); the 
Clinical Assessment Interview for Negative Symptoms (CAINS) (Forbes et al., 
2010); and the Brief Negative Symptom Scale (BNSS) (Kirkpatrick et al., 2010). It 
was found that the intervention led to moderate effects on NSA-16 and CAINS but 
not BNSS; this was suggested to be due the former instruments being more sensitive 
to change. Though both dimensions of negative symptoms were targeted, the 
intervention was found to only have an impact on motivation but not emotional 
expression. As decreased overall cognitive performance was associated with 
diminished expression but not apathy by Hartmann-Riemer et al. (2015), it is 
possible that there is a stronger link between cognition and diminished expression 
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which indicates a more treatment resistant treatment target. This is supported by the 
cognitive resource limitation theory (Cohen, Morrison, Brown, & Minor, 2012) that 
suggests that fewer resources may be available for complex expression if cognitive 
functioning is decreased. The findings suggest a need for more nuanced treatments 
that are targeted specifically at either one of the two dimensions. An alternative 
explanation of the results could be that the proposed deficits in metacognition (as 
discussed in section 1.3) did not respond to the strategies on emotional processing 
and expression that were included in the intervention. Given the limited efficacy of 
medication on other psychotic symptoms and significant side-effects, it is unclear 
why a pharmacotherapy approach rather than an advanced therapeutical approach 
was suggested to improve negative symptoms.  
 
Attempts have also been made to develop an intervention to directly improve 
metacognitive functioning as a way of targeting negative symptoms. The 
Metacognitive Reflection and Insight Therapy (MERIT), which was developed by 
Lysaker and colleagues (Lysaker & Klion, 2017), is currently being evaluated in a 
Dutch randomized controlled trial (Van Donkersgoed et al., 2014). Though the 
intervention has been found to lead to improvements on negative symptoms, only 
case studies have been published to date (Van Donkersgoed, De Jong, & Pijnenborg, 
2016). A version of MERIT was also developed for early psychosis (MERIT-EP) by 
Vohs et al. (2017), where 20 individuals were randomised to either MERIT or TAU. 
Though the intervention led to improvements on PANSS total score, it is not 
possible to say whether the improvements were found on other subscales than 
negative symptoms as only the total score was reported. Another potentially 
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promising intervention for improving reflective functioning is mentalization based 
treatment (MBT) (Bateman & Fonagy, 2008) which has been applied in case studies 
for patients with clinical high-risk for psychosis (Debbané et al., 2016) and early 
psychosis (Brent, Holt, Keshavan, Seidman, & Fonagy, 2014). There is also an 




Several meta-analyses have found that conventional CBT, which would mainly 
target positive symptoms, may have a beneficial effect on negative symptoms 
(Wykes, Steel, Everitt, & Tarrier, 2008; Sarin, Wallin, & Widerlov, 2011; Jauhar et 
al., 2014; Velthorst et al., 2015; Lutgens, Gariepy, & Malla, 2017). The earlier meta-
analysis (Wykes et al., 2008) found a stronger effect (-0.44) for negative symptoms 
compared to the later studies; this might be due to the method employed to calculate 
effect sizes (Glass’s method), which is known to inflate effect sizes (Jauhar et al., 
2014). The differences might also be due to the lower quality of the earlier studies 
(Velthorst et al., 2015).   
 
Cognitive remediation therapy (CRT) may have an effect on negative symptoms 
through improvements in cognitive functioning and by challenging the dysfunctional 
cognitions potentially underlying negative symptoms (Veerman, Schulte, & de Haan, 
2017). Two meta-analyses have focused on this intervention for negative symptoms 
(without the distinction between primary/secondary): Cella, Preti, Edwards, Dow, & 
Wykes (2016) and Lutgens, Gariepy, & Malla (2017). Cella et al. (2016) found a 
small reduction post intervention and at follow-up compared to TAU and to an active 
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control group. Encouraging, this reduction was larger in studies with a more robust 
design. Similar results were found by Lutgens et al. (2017) though a high level of 
heterogeneity was found between studies.     
 
Meta-analyses have provided further support for psychosocial interventions for 
negative symptoms. In an extensive meta-analysis by Fusar-Poli et al. (2015), CBT, 
CRT, and music therapy were all found to have a significant effect on negative 
symptoms. This was also found for Integrated Psychological Therapy (IPT) (Roder, 
Mueller, & Schmidt, 2011); mindfulness (Khoury, Lecomte, Gaudiano, & Paquin, 
2013); and Social Skills Training (SST) (Turner et al., 2017). Meta-analyses have 
also shown that negative symptoms are improved by different types of physical 
exercise (Lutgens et al., 2017; Veerman et al., 2017). The findings suggest that 
psychological interventions are likely to be effective for treating negative symptoms 
but that more research is needed to understand mechanisms of change. This is 
especially important as Fusar-Poli et al (2015) found in their meta-analysis that 
whilst most treatments (e.g. antipsychotics, antidepressants, psychological 
interventions) have a significant effect on negative symptoms, none of these changes 
were found to be large enough to be clinically meaningful.  
 
1.5. Metacognitive Training (MCT) for psychosis 
 
Metacognitive Training (MCT) (Moritz & Woodward, 2007) is a relatively new 
intervention that draws on CBT, CRT, and psychoeducation. The aim of the 
intervention is to sow “the seed of doubt” in a neutral context with the intention that 
discussing various examples as well as personal experiences will lead individuals to 
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gain insight and practical strategies (Schneider & Andreou, 2014). The intervention 
is hence based on two premises: that cognitive biases play a role in the development 
and maintenance of psychotic symptoms and that these, as well as the associated 
distress, can be alleviated by targeting underlying cognitive processes (Pos et al., 
2018).  
 
The cognitive distortions covered in MCT are based on a review by Garety & 
Freeman (1999) and include: jumping to conclusions (JTC); impairments in social 
cognition/theory of mind; attributional distortions; and affective biases. Two 
additional cognitive biases (over-confidence in errors and a bias against 
disconfirmatory evidence) were added by Moritz & Woodward (2007). In addition, 
two modules (on self-esteem and stigma) were added in 2015 as individuals 
diagnosed with schizophrenia often suffer from low self-esteem (Sundag, Lincoln, 
Hartmann & Moritz, 2015) and are subjected to prejudices (Świtaj, Grygiel, 
Anczewskaa, & Wciórkaa, 2015). These modules were also added as many patients 
consider emotional distress a more important treatment target than psychotic 
symptoms (Kuhnigk, Slawik, Meyer, Naber, & Reimer, 2012); this is important as it 
is in line with the recovery model of mental illness which “argues against just 
treating or managing symptoms but focusing on building resilience of people with 
mental illness and supporting those in emotional distress” (Jacobs, 2015, p. 117). 
 
Metacognitive training’s indirect approach, where the focus is on cognitive processes 
leading to certain beliefs rather the content of these beliefs (which would typically be 
covered in CBT), is considered beneficial for clients who cannot distance themselves 
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from their beliefs or whose self-esteem is dependent on their positive symptoms 
(Schneider & Andreou, 2014). This is important as studies have shown that 
uncovering inconsistencies in clients’ beliefs through guided discovery may 
negatively impact on the therapeutic alliance (Wittorf et al., 2013). The intervention 
further differs from CBT through its experiential format where exercises are used to 
make the subject experience the cognitive distortions in vivo during the session to 
facilitate encoding. The psychoeducational elements of the intervention, which are 
used to normalise and explain the unreliability of human cognition, are important as 
normalisation has been shown to improve treatment engagement in therapy 
(Lül mann & Lincoln, 2013). The intervention consists of eight modules that can be 
administered as a group therapy or individually (Schneider & Andreou, 2014); it has 
been recommended that the individual format might be more suitable for individuals 
with severe delusions (Moritz, Werner, Menon, Balzan, & Woodward, 2016). An 
Internet application that allows patients to access MCT material at home at any time 
is currently being tested. It is hoped that this will overcome some of the major 
challenges faced by all cognitive interventions: neuropsychological deficits, sedation 
by medication and poor motivation which, unfortunately, all limit transfer to daily 
life and comprehension (Moritz, Woodward, Balzan, 2016).  
 
Despite the similarity in name, MCT differs from the transdiagnostic “Metacognitive 
Therapy” developed by Wells which mainly focuses on dysfunctional beliefs about 
thinking (Kühne et al., 2017). A further confusion is the shared name of this 
conceptualisation of metacognition (which is closely linked to the original model by 
Flavell (1979)) and Lysaker’s model of metacognition (which is focused on intra- 
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and interpersonal functioning, see section 1.3). However, a relationship between 
Moritz’s and Lysaker’s models of metacognition has been established as jumping to 
conclusions (JTC) has been found to correlate with mastery. As correlation does not 
clarify the nature of this relationship, it might be that an inability to access 
psychological knowledge when solving problems makes an individual give up when 
faced with uncertainty, or in case of the opposite direction, that the reasoning bias in 
itself makes it difficult for an individual to think about their thinking (Buck, 
Warman, Huddy, Lysaker, 2012).   
 
Metacognitive Training has a growing evidence-base (Moritz et al., 2016). Studies 
have shown that the intervention has resulted in changes in patients’ delusion 
severity (including distress and conviction), quality of life, illness insight, memory 
functioning and cognitive biases (Balzan, Delfabbro, Galletly, & Woodward, 2014). 
In the first meta-analysis (Jiang, Zhang, Zhu, Li, & Li, 2015) on the efficacy on 
MCT, small but statistically significant reductions on positive symptoms were found. 
It is important to acknowledge though that only four studies out of 54 studies met the 
inclusion criteria due to the requirement for a randomised controlled trial (RCT) 
design and specific measurements; this limits the findings due to insufficient 
statistical power (Eichner & Berna, 2016).  
 
Two subsequent meta-analyses (Van Oosterhout et al., 2016; Eichner & Berna, 
2016) reached different conclusions: the former failed to find support for MCT on 
positive symptoms while the latter did. However, both studies were in agreement 
that MCT leads to small to medium effect sizes (Hedges’ g = .21–.34) which are 
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comparable to CBT for psychosis (Moritz, Werner, Menon, Balzan & Woodward, 
2016). The review by Van Oosterhout et al. (2016), which included 11 studies, 
reported small effect sizes of MCT on positive symptoms, delusions or data 
gathering with the majority of these being non-significant. The authors advised 
against dissemination of the intervention in routine care until more independent and 
rigorous research has been conducted. However, as pointed out in a reply by Moritz 
et al. (2016), the stringent inclusion criteria that were applied in the review led to the 
omission of several trials in favour of MCT (e.g. Aghotor, Pfueller, Moritz, 
Weisbrod, & Roesch-Ely, 2010; Erawati, Keliat, Helena & Hamid, 2014; Moritz et 
al., 2011).  
 
The most recent meta-analysis (Eichner & Berna, 2016), which included the largest 
number of intervention studies (N=15), demonstrated that MCT leads to a small to 
moderate effect on positive symptoms and delusions, and a large effect size on 
acceptance and subjective effectiveness. Even when studies with a high risk of bias 
were excluded, effect sizes for positive symptoms and delusions remained in the 
small to moderate range. Unfortunately, the review, in similarity to most studies 
finding support for MCT cannot be classified as independent as it was conducted by 
a PhD student of Moritz (Van Oosterhout et al. 2016).  
 
More research (preferably independent) into the efficacy of MCT is needed, as 
unknowns include: the mechanisms of action in terms of change (Schneider & 
Andreou, 2014); individual factors determining treatment effectiveness (including 
chronic populations and patients with low cognitive functioning) (Moritz et al., 
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2016); underlying neurobiological underpinnings (Moritz et al., 2014); the sustained 
long term effects of MCT (Briki et al., 2014); and whether the cognitive biases 
addressed in MCT lead to changes in the wider conceptualisation of metacognition 
used elsewhere in the literature (Buck et al., 2012). Ideally the research should be in 
a RCT format, include standardised outcome measures that measure cognition-
specific changes, and use intention to treat (ITT) analysis (Jiang et al., 2015).  It is 
also important to identify in further research the individual contribution of each 
module, as the duration of a typical in-patient treatment stay is too short to cover an 
entire cycle of MCT (Balzan et al., 2014; Moritz et al., 2016). Most importantly, 
more research is needed to evaluate whether MCT has an impact on negative 
symptoms.  Though more recent versions of MCT have incorporated some exercises 
that may target negative symptoms (e.g. social problems, avolition), these have not 
been evaluated (Moritz et al., 2014). Also, as suggested by Weijers et al. (2018), 
targeting mentalization may be a useful treatment approach in non-affective 
psychosis as it may improve negative symptoms.   
 
1.6. Study aims and hypotheses 
 
The purpose of this study is to adapt MCT to target negative symptoms in psychotic 
disorders (e.g. schizophrenia, schizoaffective or non-affective functional psychosis) 
as the current version focuses on positive symptoms. As negative symptoms are a 
stronger indicator of concurrent and future functioning than positive symptoms 
(Velligan et al., 2015) and as they respond poorly to medication (Veerman et al., 
2017) and existing psychological interventions (Fusar-Poli et al., 2015), there is a 
clear rationale for developing interventions targeting negative symptoms of 
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schizophrenia. This is reflected in the NIMH-MATRICS consensus statement 
(Kirkpatrick, Fenton, Carpenter, & Marder, 2006) that emphasised that persistent 
negative symptoms represent an unmet therapeutic need for patients suffering from 
schizophrenia.  
 
This feasibility study aims to address some of the gaps in the literature by modifying 
the existing MCT to explicitly target negative symptoms, addressing the relevant 
cognitions as discussed in section 1.2., and to improve metacognitive ability as 
discussed in section 1.3. Four aspects of feasibility identified by Bowen et al. (2009) 
will be addressed in this study: 
 Acceptability: how do the individual recipients react to the intervention?  
 Practicality: can the intervention be implemented and delivered in NHS settings?  
 Demand: is there a clinical need for this intervention?  
 Limited efficacy: does MCT for negative symptoms show promise for the 
intended population in terms of:  
o Reductions in negative symptoms as measured by the Brief Negative 
Symptom Scale (BNSS) (Kirkpatrick et al., 2010) and the Positive and 
Negative Syndrome Scale (PANSS) (Kay et al., 1987)? 
o Increased quality of life as measured by the Quality of Life Enjoyment 
and Satisfaction Questionnaire (Q-LES-Q-18) (Ritsner, Kurs, Gibel, 
Ratner & Endicott, 2005)? (This measure is included to reflect the 
recovery model of mental illness, which proposes that mental health 
services should aim to increase an individual’s potential for growth 
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despite residual symptoms (Ferguson, Conway, Endersby, & MacLeod, 
2009)). 
o Reductions in depression as measured by the Calgary Depression Scale 
for Schizophrenia (CDSS) (Addington, Addington, & Schissel, 1990)? 
o Improvements in reflective ability as measured by the Metacognition 
Assessment Scale Abbreviated (MAS-A) (Semerari et al., 2003) and the 
Reflective Function Questionnaire (RFQ) (Fonagy et al., 2016)? 
o Reduction in internalised stigma as measured by the Personal belief about 
illness questionnaire (PBIQ) (Birchwood, Mason, Macmillan, & Healy, 
1993)? 
o Improved functioning as measured by the Global Assessment of 
Functioning (GAF) (APA, 1987)? 
 
The research also aims to add to existing research by identifying and measuring 
potential mechanisms of change for negative symptoms (i.e. depression, reflective 
functioning, stigma). It will also add to the existing evidence base by measuring 
whether the cognitive biases addressed in MCT lead to changes in the wider 
conceptualisation of metacognition used elsewhere and by including patients with 
chronic schizophrenia. In addition, the paper will explore whether multilevel 





A pilot study with a case series design was used to assess the feasibility of applying 
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MCT to target negative symptoms in non-affective functional psychosis. A case 
series design was chosen as it allows for a focus on the mechanisms of change within 
the intervention as it provides detailed data on changes over time. It was also the 
preferred design as it reduces variance accountable to research design whilst 
providing the possibility to measure individual factors that may have an impact on 
treatment outcomes. The quantitative design was combined with a qualitative 
approach as the combination allows for one design to compensate for the other; this 
provides more comprehensive and valid results than either method alone 
(Mengshoel, 2012). Similar designs have previously been applied in severe and 
enduring mental health conditions (Greaves, Camic, Maltby, Richardson, & Mylläri, 
2012; Mairs, Lovell, Campbell, & Keeley, 2011; Heriot-Maitland, Vidal, Ball, & 
Irons, 2014).  
 
Small-N studies have a place in the clinical research process as while randomised 
controlled trials (RCT) are seen as the gold standard in research, the design is not 
suitable for every stage in the research process. A hierarchical model for the clinical 
research process has therefore been suggested, where different designs need to be 
implemented at different stages to develop, evaluate or create an evidence-base for 
an intervention (Dugard, Todman, & Todman, 2012). The chosen design for this 
research made an initial exploration of the feasibility and acceptability of the new 
intervention possible and hence provided the first stage in the evaluation of MCT for 
negative symptoms. The findings of small-N studies are required to decide whether 
interventions are appropriate for further evaluation in terms of efficacy and 
effectiveness (Bowen et al., 2009). In addition, though RCT:s have a high internal 
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validity due to their ideal conditions, it has been questioned whether the findings can 
be generalised to standard clinical practice due to the population selection 
procedures that are necessary  to limit confounding factors (e.g. depression, positive 
symptoms, substance abuse, cognitive difficulties). Pragmatic trials like this are 
hence needed to inform the effectiveness of an intervention under routine 
circumstances with real-life populations (Saturni et al., 2014)  
 
2.2. Participants, sample size, settings, and ethics 
 
Eligible participants were over the age of 16 years old and diagnosed with a 
psychotic disorder (e.g. a diagnosis of schizophrenia, schizoaffective or non-
affective functional psychosis) in the National Health Service (NHS) Lothian. 
Exclusion criteria consisted of: evidence of organic brain dysfunction or a learning 
disability that precluded them from making use of a psychological intervention; 
difficulty with the English language; visual and/or hearing impairment; or being 
unable or unwilling to provide written informed consent.  
 
A formal power calculation was not applied as the purpose of the research was to 
gather information about the process of change for individuals in MCT to inform 
future research trials. Abu-Zidan, Abbas, & Hefny (2012) suggested that a minimum 
sample size of four should be used for case-series design whilst Braun & Clarke 
(2013) has suggested that 6 to 10 subjects are sufficient for thematic analysis. These 
recommendations were taken into account during the recruitment phase of this 




The study, which ran between March 2016 and February 2018, received approval 
from the South East Scotland Research Ethics Committee (REC reference: 
16/SS/0046) and NHS Lothian Research and Development office in 2016 (see 






There were eight sessions in total in the modified MCT. Core metacognitions from 
the current MCT (see section 1.5.) were adapted to negative symptoms by 
incorporating psychoeducation and strategies designed to target the cognitions 
implicated in the development and/or maintenance of negative symptoms (see 
section 1.2.). The order of the sessions was randomised using an online random 
sequence generator. The researcher delivered MCT for negative symptoms 
individually as studies have found larger effect sizes for individual MCT than MCT 
delivered in a group format (Eischner & Berna 2016); an individual approach may 
also be more suitable for this patient group as group MCT is not recommended for 
patients with severe delusions (Moritz et al., 2016). Individual MCT also had the 
advantage of facilitating recruitment in the pilot study. The developer of MCT for 
schizophrenia (Professor Steffen Moritz) approved the modification of the 
intervention for negative symptoms. Every session started with a short summary of 
what negative symptoms are and how certain unhelpful cognitions (see section 1.2.) 









Introduction to negative symptoms (developed for MCT for negative 
symptoms) 
 
Psychoeducation, exercises, and discussion on what negative symptoms are and 
how certain unhelpful cognitions (e.g. negative beliefs towards social 
engagement and low expectancy of pleasure/success) might lead to and 
maintain negative symptoms.  
 
Also strategies for challenging unhelpful cognitions (e.g. monitor unhelpful 
cognitions and take mental snapshots and/or write down enjoyable and sociable 






Self-esteem (taken from the additional modules from original MCT) 
 
Psychoeducation, exercises, and discussion on what self-esteem is and how low 
self-esteem and rumination might lead to and maintain negative symptoms (e.g. 
not attempting activities or not engaging with others due to fear of social 
judgement). 
 
Also strategies for challenging low self-esteem and rumination (e.g. becoming 
aware of social comparison, asking others what they value the person for, 
writing down achievements in a “joy diary”, cognitive defusion, physical 






Jumping to Conclusions (JTC) (modified from original MCT) 
 
Psychoeducation, exercises and discussion on JTC and how this might lead to 
and maintain negative symptoms (e.g. disengagement due to mind-reading 
and/or fortune telling).  
 
Also strategies for challenging JTC (e.g. consider alternative interpretations; 
check that enough information has been gathered before drawing a conclusion 
(especially if it is a significant decision); checking with others). 





Attribution Style (modified from original MCT) 
 
Psychoeducation, exercises, and discussion on how a one-sided explanation 
style might lead to and maintain negative symptoms (e.g. blaming oneself for 
failures and give others or circumstances credit for successes which might lead 
to social withdrawal and emotional shut down).  
 
Also strategies for challenging attribution style (e.g. consider that multiple 
factors (i.e. oneself, others and the situation/circumstances) might contribute to 









Cognitive Difficulties (modified from original MCT)  
 
Psychoeducation, exercises and discussion on how common cognitive 
difficulties in psychosis (i.e. verbal memory, mental flexibility, attention) may 
lead to and maintain negative symptoms (e.g. difficulties with planning may 
lead to avolition) but that the relationship might also be the opposite (e.g. brain 
becoming “rusty” due to long-term avoidance) or be due to other variables (e.g. 
low expectancy of success leading both to avolition and motivational 
difficulties/anxiety when engaging in cognitively demanding tasks).  
 
Also strategies to deal with cognitive difficulties (e.g. mnemonics, problem 






Social Cognition (modified from original MCT) 
 
Psychoeducation, exercises and discussion on how difficulties detecting and 
evaluating facial expressions (which may be due to expected social rejection) 
might lead to and maintain negative symptoms (e.g. not gaining pleasure from 
social interactions as they are perceived as confusing). 
 
Also strategies for understanding what others mean or feel (e.g. gaining 
knowledge from environment/situation, self-observation, gut feeling).     





Mood (taken from original MCT) 
 
Psychoeducation, exercises and discussion on how depression may lead to and 
maintain negative symptoms through the loss of drive and motivation to engage 
with the world and social isolation due to fear of being rejected.  
 
Also strategies (e.g. cognitive restructuring, writing down strengths, 
compliments and positive things from the day in a “joy diary”, cognitive 
defusion, do enjoyable things, remember previous enjoyable events with all 
senses, exercise) for overcoming certain cognitive traps (e.g. exaggerated 






Stigma (taken from the additional modules from original MCT) 
 
Psychoeducation, exercises and discussion on how stigma may lead to and 
maintain negative symptoms (e.g. disengagement due to internalisation of the 
incorrect view of psychosis that is portrayed by the media (e.g. dangerous, low 
IQ)).  
 





2.4. Outcome Measures 
 
In the study a combination of interviews and self-rated questionnaires were used (see 
below). As consideration to participation burden was given throughout the study 
(Newington & Metcalfe, 2014), only instruments that measured the specific 
constructs of interest in a reliable and time efficient way were applied.  All the 
outcome measures were administered and interpreted by the primary researcher who 
had training in the specific measurement (PANSS) or accessed resources (BNSS; 
MAS-A) from the developers to undertake this independently. A Kappa-coefficient 
of 0.70 for overall agreement between the primary researcher and a research 
collaborator (E.E.) on all three measures indicated adequate inter-rater reliability 
(Randolph, 2008). The total scores were used for all subscales with the exception of 
PANSS. 
2.4.1. Positive and Negative Syndrome Scale (PANSS) (Kay et al., 1987) 
 
The Positive and Negative Syndrome Scale (PANSS) is one of the most widely used 
tests for assessing positive and negative symptoms in schizophrenia. Though 
evidence of internal reliability was established for the original measure in previous 
studies (Cronbach’s alpha < .70 for all scales), the original structure of grouping 
items into scales for positive, negative and general psychopathology is questioned in 
contemporary research; instead a five-factor model that includes positive symptoms, 
negative symptoms, disorganisation, depression, and excitement is suggested as it 
seems to better capture the symptoms present in schizophrenia (Bagney et al., 2015). 
The negative factor (N1, N2, N3, N4, N6, G7) of the five-factor model as proposed 
by NIMH researchers Wallwork et al. (2012) will therefore be used in this study.  
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2.4.2. The Brief Negative Symptom Scale (BNSS) (Kirkpatrick et al., 2010) 
 
The Brief Negative Symptom Scale (BNSS) is an assessment of negative symptoms 
developed to address recommendations from the NIMH consensus development 
conference on negative symptoms in 2005 (Strauss et al., 2012). The scale has strong 
inter-rater, test–retest, and internal consistency with intra-class correlation 
coefficients of .93. Its validity is also supported by its relationship with two other 
commonly used scales for assessing negative symptoms (i.e. SANS and PANSS) 
2.4.3. The Metacognition Assessment Scale Abbreviated (MAS-A) 
(Semerari et al., 2003) 
 
The abbreviated version of the Metacognition Assessment Scale (MAS-A) was used 
to assess metacognitive ability. The MAS-A is scored on transcripts generated with 
the Indiana Psychiatric Illness Interview (IPII) (Lysaker, Clements, Plascak-
Hallberg, Knipscheer & Wright, 2002); the interview consists of five open questions 
to elicit the patient’s life story and illness history (Van Donkersgoed et al., 2014). By 
analysing the narratives with the MAS-A, three components of metacognition are 
assessed: understanding one’s own mind, understanding the mind of others, and 
mastery in the ability to think purposefully regarding a particular problem or source 
of distress. The MAS-A has shown good inter-rater reliability with intra-class 
correlations of .89 (Lysaker et al., 2005).  
2.4.4. The Calgary Depression Scale for Schizophrenia (CDSS) (Addington 
et al., 1990) 
 
Measuring depression in schizophrenia represents a challenge as many widely used 
scales (e.g. the Hamilton Depression Scale (Hamilton, 1960)) are influenced by 
negative symptoms. The Calgary Depression Scale for Schizophrenia (CDSS) was 
developed to overcome this problem. The scale, which consists of a structured 
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interview with nine questions, has good reliability and validity (Schennach et al., 
2012).  
2.4.5. The Personal belief about illness questionnaire (PBIQ) (Birchwood et 
al., 1993) 
 
The Personal belief about illness questionnaire (PBIQ) was used to measure clients’ 
view of their condition and the impact this has on their future, social status, and 
social marginalisation. The self-administered assessment has five subscales: control 
over illness, self as illness, expectations in relation to independence, stigma, and 
social containment. The measure has been widely used to study how individuals 
adapt to psychosis and has extensive psychometric validation (Acosta, Aguilar, 
Cejas, & Gracia, 2013).  
2.4.6. The Quality of Life Enjoyment and Satisfaction Questionnaire (Q-
LES-Q-18) (Ritsner et al., 2005) 
 
The Quality of Life Enjoyment and Satisfaction Questionnaire (Q-LES-Q-18) is a 
short, self-administered questionnaire based on the Quality of Life Enjoyment and 
Satisfaction Questionnaire (Q-LES-Q) (Endicott, Nee, Harrison, & Blumenthal, 
1993). The Q-LES-Q-18 has shown high reliability, validity, and stability of test-
retest ratings in patients with severe mental illness (schizophrenia, schizoaffective 
disorder and mood disorder) (Ritsner et al., 2005).  
2.4.7. The Global Assessment of Functioning (GAF) (APA, 1987) 
 
 The Global Assessment of Functioning (GAF) is a rating scale for assessing a 
person’s psychological, social and occupational functioning. The scale has been 
found to have good reliability even with limited practitioner training (Jones, 
Thornicroft, Coffey, and Dunn, 1995). Although there are validity and reliability 
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issues with the scale (Aas, 2010), it will be used in this study due to the fact that it is 
the most commonly used scale for assessing impact of mental illnesses in clinical 
practice and research.  
2.4.8. The Reflective Function Questionnaire (RFQ) (Fonagy et al., 2016) 
 
The Reflective Function Questionnaire (RFQ) is a 46-item self-reported 
questionnaire that was developed by Fonagy & Ghinai (unpublished manuscript) to 
assess mentalising capacity in adults (Ha, Sharp, Ensink, Fonagy, & Cirino, 2013). 
The scale consists of statements where the subject rates (1-6) the extent to which 
they agree. The measure has been found to have good internal consistency and re-test 
reliability (Fonagy et al., 2016).    
2.5. Procedure 
 
The researcher provided information about the project to mental health teams who 
referred participants. Subjects were provided with written information about the 
research and referred to the researcher if they chose to take part. The researcher met 
with the subjects prior to participation to obtain written consent, to gather relevant 
demographic information, and to complete the baseline measures which included 
PANSS; BNSS; MAS-A; CDSS; PBIQ; Q-LES-Q-18; GAF; and RFQ. Participants 








Table 2. Timing of measurement. 






Baseline X X X X (+3X)* 
Session 1 X    
Session 2 X    
Session 3 X    
Session 4 X  X  
Session 5 X    
Session 6 X    
Session 7 X    
Session 8 
(Post) 
X X X X 
Follow-up X X X X 




Subjects completed three session-by-session measures: BNSS to assess negative 
symptoms, Q-LES-Q-18 to assess quality of life, and CDSS to assess whether the 
outcome on the other measures could be due to depression; only these brief measures 
were completed at each individual session to decrease participation burden. In 
addition, the PBIQ was administered after sessions (3 in total) that focused on self-
stigma, or psychological processes (i.e. depression and low self-esteem) that are 
known to be associated with the “Why Try” phenomenon (i.e. when individuals 
perceive themselves as incapable of achieving personal goals due to internalisation 
of stereotypes of mental illness) (Corrigan, Larson, & Ruesch, 2009; Corrigan, Bink, 
Schmidt, Jones, & Rüsch, 2016). The RFQ was administered after the subjects had 
completed half the intervention to monitor metacognition over time. All measures 
were administered at a follow-up 12 weeks after to see if the intervention had a long-
term effect. Subjects were asked to attend an individual exit interview between one 
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and two weeks after finishing the intervention. The interview was recorded with a 




Descriptive statistics on recruitment and attendance rates were combined with the 
participants’ perspectives of the intervention to explore the feasibility and 
acceptability of the intervention. Wilcoxon Signed Rank tests were used to evaluate 
whether the intervention led to improvements on negative symptoms, quality of life, 
depression, reflective ability, stigma; and global functioning whilst multilevel 
modeling methods (MLM) were used to identify mechanisms of change.  
 
2.6.1. Quantative Data Analysis 
 
SPSS (version 23), R (version 3.4.3) and Excel (Excel for Mac 2011) were used for 
the statistical analysis. Missing data on questionnaires was replaced with case-mean 
substitution if less than 20% of the items were missing as this has been found to be a 
robust way of handling data missing on an item level (Fox-Wasylyshyn & El-Masri, 
2005). For measures that were not administered each session (i.e. RFQ and PBIQ), 
the score of the last measurement was used for the session-by-session analysis 
during the active treatment phase unless the measure was missing or excluded. 
Wilcoxon Signed Rank tests were chosen for the pre, post and follow-up analysis as 
it is a non-parametric equivalent to the dependent t-test; this was deemed as 
appropriate due to the limited sample size and the repeated-measure nature of the 
data (Field, 2009). 
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Multilevel modeling (MLM) was used to explore change over time. The analysis has 
increasingly been used for analysing case series data (Collins & Sayer, 2001; Singer 
& Willet, 2003; Twisk, 2010). The method is considered an appropriate statistical 
analysis for case series if the aim of the study is to assess change over time and 
across cases as MLM can manage missing data as well as varying time points across 
individuals (Baek et al., 2011). In addition, MLM does not, unlike most other 
statistical analyses, assume that observations are independent which is unlikely when 
analysing data over time for the same individuals where time points may be 
correlated. Recent studies have provided evidence of the efficacy of MLM when 
applied in case series (e.g. Moeyaert, Ferron, Beretvas, & Van den Noortgate, 2014; 
Rindskopf & Ferron, 2014; Shadish, Kyse, & Rindskopf, 2013). The visual slope 
was used to explore trends (i.e. the average slope, direction of the dependent 
variables and individual variance across time).  
 
2.6.2. Qualitative Data Analysis 
 
Thematic analysis (Braun & Clark, 2006) was used in conjunction with the 
quantitative analysis to evaluate the feasibility and acceptability of Metacognitive 
Training for negative symptoms in psychotic disorders. The qualitative exit 
interviews were audio recorded and ranged in length from 8 minutes 36 seconds to 2 
minutes 9 seconds (Mean = 3 minutes 42 seconds). A standardised interview 
schedule (with open-ended questions) was applied to minimise variations in 
questions asked in different interviews whilst still retaining enough flexibility to 
assess individual experiences  (Patton, 1987). The interviews were transcribed by the 
primary researcher and transcripts were read multiple times to become familiar with 
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the material and to generate an overall view of the responses (Mairs, Lovell, 
Campbell, & Keeley, 2011). The recordings were then analysed with thematic 
analysis conducted according to a standard format (i.e. exploring the feasibility of 
the intervention and potential mechanisms of change). Themes were developed, 
labelled, and reviewed to assure that they were representative of the overall dataset. 
This analysis was undertaken by the primary researcher, and then discussed with a 




3.1. Sample characteristics 
 
A total of 45 patients were referred to the research study, which was conducted over 
16 months. Of these, 18 subjects (40%) agreed to take part in the study. The most 
common reason for declining to take part was that patients did not want to be 
recorded (despite it being explained to patients that recording was not necessary). 
Three patients were excluded as they were unable to give informed consent due to 
paranoid delusions and/or severe cognitive difficulties. The patients were recruited 
from two mental health services at the Royal Edinburgh Hospital: the Psychiatric 
Rehabilitation Service (N=10) and the Acute Psychiatric Services (N=5), though 
three of the participants from the Acute Services transferred to the Rehabilitation 
Service during the study.  
 
In total, 13 (87%) of the 15 subjects that were included had schizophrenia as a main 
diagnosis while two (13%) had schizoaffective disorder. 13 subjects (87%) were 
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receiving Clozapine, one (6.5%) was receiving Risperidone, and one (6.5%) was 
receiving Amisulpride. Of the 15 subjects, 8 (54%) had not completed secondary 
education. The subjects were receiving either in-patient care (N= 10, 67%) or being 
seen in the community (N=5, 33%). In total, 10 (67%) of the patients were currently 
seen or had been seen by the Psychology Department previously. The mean age for 
the overall sample was 42.6 years (sd=11.53). Of these 15 individuals, thirteen were 
male (mean age of 40.31 years, sd= 9.87) and two (13%) were female (mean age of 
57.5 years, sd= 13.43). The participants were either referred by their Psychiatrist 
(N=5), Key Worker (N=4), Psychologist (N=4), or self-referred (N=2). The average 
number of sessions attended was 6.33 (sd= 2.67). In total, 10 of the 15 subjects 
completed all 8 sessions, 1 subject 6 sessions, 1 subject 5 sessions, 2 subjects 2 
sessions, and 1 subject only completed baseline measures. The reasons for 
discontinuing the intervention were chaotic lifestyle due to substance abuse, 
difficulties with concentration as a side-effect of medication changes, significant 
bereavement, and severe depression.   
 
3.2. Quantitative Analysis: Symptom change over time for 
completers 
 
Multiple of Wilcoxon Signed Rank tests were applied to compare the differences in 
scores pre, post, and at follow-up (see Table 3 and Figure 4). A statistically 
significant decrease in symptom severity was found on negative symptoms on BNSS 
with medium effect sizes post intervention (Mdn= 16), z = -2.39, p = .017, r = -.75 
and large effect sizes at follow-up (Mdn= 9.5), z = -2.52, p =.012, r = -.89. It was 
also found that the intervention led significant improvements on reflective 
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functioning post intervention (Mdn=192), z = -1.99, p= .046, r = -.75 which 
increased at follow-up (Mdn= 203) though this was not found significant, z = -1.07,  
p = .28, r = -.04. The intervention did not lead to any significant differences post 
intervention on negative symptoms as measured by PANSS; quality of life as 
measured by Q-LES-18; depression as measured by CDSS; metacognitive 
functioning as measured by MAS-A; or improved functioning as measured by GAF. 
The analysis indicated that internalised stigma as measured by PBIQ decreased to a 
significant level at follow-up (Mdn= 36), z = -2.05, p = .04, r = -.77. 
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Table 3. Wilcoxon sign test for completers pre and post 
Variable Median Median Z P r Median Z P R 
 Pre Post 
 
   Follow-
up 
   




-2.39a .017* -.75 9.5 
(N=8) 
-2.52a .012* -.89 
Positive and Negative Syndrome 
Scale (PANSS) Negative symptoms  
13 13 
(N=9) 
-1.34a .182 -.45 13 
(N=5) 
-1.83b .068 -.81 
Quality of Life Enjoyment and 




-.06a .953 -.02 54.5 
(N=8) 
-.31b .75 -.11 
Calgary Depression Scale for 
Schizophrenia (CDSS)  
5 4.50 
(N=10) 
-.83b .40 -.26 3.50 
(N=8) 
-1.27b .20 -.45 
Metacognition Assessment Scale 
Abbreviated (MAS-A)  
12 12 
(N=3) 
.00c 1.00 .00 n/a n/a n/a n/a 




-1.99b .046* -.75 203 
(N=3) 
-1.07b .28 -.62 
Personal beliefs about illness 
questionnaire (PBIQ)  
34 37 
(N=8) 
-.52a .60 -.18 36 
(N=7) 
-2.05a .04* -.77 




-.58b .56 -.18 40 
(N=8) 
-1.00b .32 -.35 
a= based on positive ranks 
b= based on negative ranks 






Figure 3. Pre-post mean symptom change for completers.  
 
3.3. Quantitative Analysis: Modeling symptom change using 
multilevel modeling 
 
Several models were applied to the data to assess potential mechanisms of change 
over time. Model 1 (which subsequent models were built on) evaluated whether 
there was enough variance (i.e. differences in negative symptoms) between subjects 
to apply subsequent models. Model 2 evaluated whether time had an effect (i.e. 
whether negative symptoms changed over time). Predictor variables were then added 
to the model to establish the effect of certain predictors (Model 3 (depression), 
Model 4 (stigma), and model 5 (reflective functioning)). Due to the limited sample 
size, the predictors were analysed individually meaning the effects were not 
cumulative. Parameters for the models can be found in Table 4 for the whole sample 
and Table 5 for the participants who completed the intervention. 
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The initial variance was analysed in Model 1 (see Table 4). The intra-class 
correlation coefficient (ICC) was calculated to be 0.75, meaning approximately 75% 
of the variance in negative symptoms was attributable to between-subject variance; 
this indicated that there was enough variance to apply subsequent models. When 
time was added in Model 2, it was found to be significant and improved the fit of the 
model as the unexplained variance decreased from 809.75 to 773.80. This indicates 
that negative symptoms significantly decreased over the course of the therapy. 
Analyses were then applied to the ten completers and similar results were found. The 
impact of depression on negative symptoms was explored in Model 3 which found a 
strong relationship between depression and negative symptoms as measured by 
BNSS. This suggests changes in negative symptoms over time were partially due to 
improvements on depression.  Changes in negative symptoms were also found to 
relate to stigma (Model 4) as this improved the model fit even further. Reflective 
functioning (Model 5) was found to improve the model fit most of the three 
predictors. Similar patterns were found for the completers (see Table 5) where, in 
addition, depression was found significantly associated with negative symptoms. The 
MLM hence indicates that though depression and stigma are important predictors of 
negative symptoms, reflective functioning explains most of the changes over time on 
negative symptoms. As can be seen from graphs of the slopes (see Figure 4), all 
subjects who completed the intervention improved on negative symptoms as the 
scores decreased over time as seen through the slope’s direction. In addition, when 
looking at changes over time on quality of life (see Figure 5) and not just pre and 
post measure, it was also found that the participant’s quality of life improved over 
time due to the direction of the slope.    
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Table 4. Summary parameters with Brief Negative Symptom Scale (BNSS) as dependent variable (whole sample) 
























Time  -1.49(.22) 
*** 





  .19(.23)   





   .25(.28)  





    -.03(.12) 




809.75 773.80 741.32 674.52 586.96 
Parentheses values = standard errors; ***p<.001, **p<.01, *p<.05 
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Time  -1.47(.24) 
*** 





  -.34(.31)   







   .08(.35)  





    .02(.13) 




688.27 657.22 627.81 574.73 479.41 








Figure 5. Improvements on quality of life as measured by the Quality of Life Enjoyment and Satisfaction Questionnaire (Q-LES-Q-18) 
over time for completers.  
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3.4. Qualitative Data analysis  
  
All 10 completers agreed to take part in the interview about their views on the 
intervention. They were asked six questions in total (see Appendix F). 15 categories 
were identified in the thematic analysis; these were grouped into three themes: 
acceptability changes post intervention, and the therapeutic alliance. As four subjects 
(p7, p8, p9, p10) did not want to be recorded, their answers were written down by the 
researcher.  
 




All participants were able to identify some positive aspects of the intervention. These 
mainly included the psychoeducational aspects, skills development, and the 
therapeutic relationship. Though not explicitly relevant to the intervention, several 
participants reported that they enjoyed contributing to the research as it would 
potentially help others with psychosis.  
“I would recommend it to other people”. P1 
“I enjoyed it. I learned a lot about myself. It was also giving me coping mechanisms 
for when I am in trouble mentally. It has helped me a lot”. P4 
“Hard work sometimes but I got a lot from it. I think I have learnt from it, so it’s 
been good”. P5 




3.4.1.2. Negative:  
 
Most subjects said that the single most negative aspect of taking part in the research 
was completing questionnaires. In terms of what was less useful, one participant felt 
that the intervention was not relevant to her as she did not agree with her diagnosis 
of schizophrenia but felt that she had symptoms of trauma. Another patient said that 
the computer made him feel “paranoid” at times. It was possible some patients had 
false expectations of the outcome of taking part as one patient expressed 
disappointment that taking part in the research had not resulted in him being 
discharged.   
“Helpful but paperwork and computer said psychosis where I have trauma and no 
psychosis”. P8  
“The computer made me feel paranoid at times”. P9 
“It is not going to speed up discharge…” P2 
 
3.4.2. Changes after taking part in the intervention 
 
Most participants said that they had reflected more on their own thinking after taking 
part in the intervention. This mirrors the quantitative results in the previous section 
which found that negative symptoms seemed to improve as a result of improved 
metacognitive functioning.   
“I learned a lot about myself”…. “It made me think about myself in a different 
way”. P4 
“It made me think about things about myself that I hadn’t noticed before”...”I am 




Several participants stated that they had noticed how certain unhelpful thinking 
patterns (conceptualised by most subjects as “negativity” but seemed to include a 
high degree of expected social rejection, devaluation of relationships, or expected 
failure) had a direct impact on their everyday functioning. Participants also 
mentioned that they felt that they had developed skills during the intervention which 
helped them to modify these cognitions.  
“I learned that I can actually do things together with other people, it is all in my 
head, that I need to do things just on my own”… “I am less self-critical and kinder 
to myself now”. P6  
“I am not thinking as negatively now as before”. P7 
 “I am a bit paranoid for the moment but I got no reason to be, but I am. So I said to 
myself when I am walking into a shop and everyone is looking at me that is to do 
with the fact that I only got one arm, and that it is not anything personal”. P4 
 “I thought about my negative ways in the past, and how I have changed them”. P1 
 
It was also reflected in the transcripts how awareness of these unhelpful thinking 
patterns (i.e. metacognition) had lead to the development of adaptive coping 
strategies.  
“It was giving me coping mechanisms for when I am in trouble mentally. It has 
helped me a lot”….”I would never have gone on a bus but what you taught me, 
about getting on the bus and people are just exactly as you, so I learned from that 
that I can get on a bus”…“I can get out outside. You probably wouldn’t understand 
it, I don’t know if you have been through it yourself but you are getting cabin fever 
by only being inside. And when I go outside, I might be a bit paranoid, and a bit 
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scared, but yeah when I come back I feel a lot better. So it has helped that way”… 
“If you went back just a few weeks ago, and I was in the state that I am now 
(referring to the distress that he felt when ending therapy), I think it might have been 
a different outcome. I might have self-harmed. I would definitely have self-harmed”. 
P4 
 “I am trying a bit harder to socialise. I went out with XXX yesterday and I was 
making jokes and laughed. I went to the barber shop Wednesday and had a great 
laugh so it’s helping with my social confidence. That makes me feel good”… P5 
“I learned that I can do things to make me think and feel differently”… “That if I 
work purposefully and hard, things can be done which wouldn’t happen if I just 
think”. P6 
“I am more objective in my ability to motivate myself to do things which means that I 
am more active now”. P7 
 
It was also mentioned in several of the transcripts that the psychoeducational 
elements around psychotic symptoms had helped subjects to address internalised 
stigma.  
 “I understood how different aspects of negative symptoms leads to a psychotic 
illness”. P2  
“It was alright, it was insightful because I didn’t really understand what psychosis 
was”.  P3 
“I understand my illness more now and I know that it is just my mind playing tricks 
which makes the psychosis feel less real”. P10 
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3.4.3. The therapeutic alliance 
 
Most participants commented on how they had enjoyed taking part in the 
intervention due to the therapeutic alliance. This seemed to centre around two 
categories: the “cathartic” value of seeing the researcher and the therapeutic space as 
a way to reflect and problem-solve.  
 “It helped me. I got my feelings out” P1 
“It didn’t help me surviving everyday life in the ward but talking and thinking about 
my family did”… “That was the best bit, talking about my family... Taking it off your 
chest, that’s useful”.  P2 
 “If you talk about it, you can solve it. Talking solves. Sitting talking, and the best 
ideas will come out. Just you being there Linda, it’s partly you. Me and you, 1:1”. 
P1 
 “It helped me to express myself, that Linda listened to me and knows where I am 




The primary aim of the research study was to evaluate the feasibility of MCT 
modified for negative symptoms in terms of acceptability, practicality, demand and 
limited efficacy. A secondary aim was to evaluate whether MCT could be used to 
improve reflective ability and to identify mechanisms of change in negative 
symptoms. The study also explored the use of MLM as a statistical approach for the 








In terms of acceptability, 40% of the patients who were asked to participate agreed to 
take part. This means that the intervention had a slightly higher success rate in 
recruitment than other studies for negative symptoms (e.g. 25% in Staring et al. 
(2013)). It is possible that this might have been the design of MCT in comparison to 
CBT as the participants were not required to share sensitive information to the same 
degree (sharing personal information can be threatening to those applying a coping 
strategy of disengaging with others to avoid perceived judgement).  
 
The dropout rate during the active phase of therapy was found to be 33% (5 of 15 
subjects) which is similar to other studies (e.g. 43% for CR and 25% for CBT in the 
study by Klingberg et al (2011) and 23% in the study by Velligan et al (2015)). 
However, it is higher than the studies undertaken by Beck and colleagues (i.e. 15% 
in Grant et al. (2012) and 14% in Staring et al. (2013)), which might be explained by 
the fact the study recruited from a chronic and treatment resistant patient population. 
A recent meta-analysis (Fernandez, Salem, Swift, & Ramtahal, 2015) of the dropout 
rate for CBT for various mental health disorders which covered more than 20,000 
participants found that the weighted average during treatment was 26% which is 
similar to this study. Following completion, all subjects were able to identify aspects 
of the intervention that they valued; this included receiving psychoeducation on 
psychosis, skill development (including metacognitive ability), and the therapeutic 
relationship.   
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4.1.2. Practicality  
 
As the intervention was manualised, it is a practical treatment option that could be 
delivered with ease and implemented into standard care in an NHS setting. It 
required minimal preparation before sessions as the only task prior to seeing a 
patient was to print off the homework sheets. The practical aspect of MCT might be 
the reason, as pointed out by Van Oosterhout et al. (2016), it has been disseminated 




The researcher received feedback from the clinical team indicating, as expected, that 
there was a clear demand for the intervention. This included positive feedback from 
several psychiatrists who welcomed the development of an intervention to target 
negative symptoms given the lack of evidence-based interventions available. It also 
included feedback from other clinicians who expressed an interest in using it. 
Overall, this indicates that the intervention had good feasibility in terms of 
acceptability, practicality, and demand. However, it should be acknowledged that the 
trial methodology might have led to more favourable outcomes than would have 
been found if the intervention had been delivered and implemented by professionals 
in a standard NHS care setting.  
 
4.1.4. Limited efficacy 
 
As this was a case-series design, limited conclusions in regards to efficacy can be 
made. However, based on this small sample, it was found that the intervention led to 
significant improvements on negative symptoms as measured with BNSS. This 
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supports the findings of other studies (Klingberg et al., 2011; Grant et al., 2012; 
Staring et al. 2013, Velligan et al., 2015) that show negative symptoms respond to 
psychological interventions. As Velligan et al. (2015) found that other measures of 
negative symptoms (i.e. the NSA-16 and the CAINS) were more sensitive to change 
than BNSS, it is possible that a larger effect would have been found in this study if 
alternative measures had been used. Contrary to Klingberg et al. (2011), this study 
did not find any significant improvements when using the five-factor model on the 
negative subscale of PANSS. This might be due to sampling difference as Klingberg 
et al. (2011) had a highly selective sample where patients with a significant degree of 
depression, positive symptoms, cognitive difficulties or substance abuse were 
excluded. It might also be because patients received more sessions (N=20) over a 
longer period of time (9 months), or because patients were seen on an outpatient 
basis indicating they had a higher level of social functioning. The lack of significant 
findings on the PANSS might be due to the fact that the measurement, in contrast to 
BNSS, does not assess expectations or experiences in relation to pleasure (i.e. 
anhedonia) (Daniel, 2013) which would have been targeted and potentially improved 
by the intervention.   
 
This study also found that subjective quality of life did not significantly improve 
over time which is similar to previous research targeting negative symptoms in 
schizophrenia (Daniels, 1998). As no recent studies on negative symptoms include 
measures of quality of life (Klingberg et al., 2011; Grant et al., 2012; Staring et al.,  
2013; Velligan et al., 2015), it is difficult to conclude how this relates to more recent 
studies. The result might be due to the sample mainly consisting of unmarried adult 
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men with depression and negative symptoms in an in-patient setting who have 
suffered from psychosis for many years as quality of life in schizophrenia has been 
found to be negatively affected by older age, being male, length of illness, negative 
symptoms, depression and being institutionalised (Bobes, Garcia-Portilla, Bascaran, 
Saiz, & Bouzoño, 2007); it is hence possible that the sample represent a subgroup 
that are particularly difficult to treat. The results might also be due to methodological 
issues as research has indicated that reported subjective quality of life in 
schizophrenia may be affected by depressive and psychotic symptoms, 
metacognitive and cognitive deficits, and poor insight which may then threaten the 
validity and reliability of measures (Hayhurst, Massie, Dunn, Lewis, & Drake, 2014; 
Nishiyama & Ozaki, 2010; Boyer et al., 2012). Alternatively, it is possible that a 
significant effect would have been found if the sample size had been larger as the 
slopes in the visual inspection demonstrated positive results for all subjects on 
quality of life. The lack of significant differences at CDSS might be due to the fact 
that intervention did not explicitly target depression.  
  
In addition, the study found no improvements on GAF. This measure might have 
been too crude to detect psychosocial changes in this population as suggested by 
previous research (Robertson et al., 2013). Contrary to the case study by Van 
Donkersgoed et al. (2016) that used the MAS-A to assess change following MERIT, 
no changes pre and post intervention were found on the MAS-A in this study; this 
might be due to the chronicity of the patients in this study. However, it seemed like 
the feasibility for the MAS-A was low as only five participants completed it at 
baseline and three post intervention. The main reason for not wanting to be 
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interviewed was a reluctance to be recorded. The oral feedback from the patients 
who completed the interview at two time-points was that they felt that they had 
already shared their life story with the researcher once and were reluctant to repeat 
this. It is possible that reluctance to re-tell their life story had an impact on their 
overall score as significant differences were found pre and post intervention on the 
other measurement of mentalization, the RFQ. Self-perceived improvements were 
also seen in the qualitative feedback from the participants.  Finally, the study found 
that the intervention led to significant improvements on internalised stigma which is 
in line with previous research on the relationship between negative symptoms and 
stigma (Hill & Startup, 2013) as well as the qualitative results of this study. It should 
be acknowledged though that the intervention overall only led to modest effect sizes 
which, as previously discussed, is similar to other intervention studies on negative 
symptoms.   
 
4.2. Mechanisms of change 
 
This study adds to the research on mechanisms of change involved in treating 
negative symptoms by showing that reflective ability improved the fit of the model 
more than depression and internalised stigma. A link between negative symptoms 
and reflective functioning is also suggested as reflective ability and negative 
symptoms were the only measured constructs that significantly improved post 
intervention. This provides support for the metacognitive model of negative 
symptoms suggested by Lysaker and colleagues and is hence in agreement with 
previous research (Mitchley, Barber, Gray, Brooks, & Livingston, 1998; Doody, 
Götz, Johnstone, Frith, & Owens, 1998; Garety & Freeman, 1999; Greig, Bryson, & 
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Bell, 2004; Sergi et al., 2007). In addition, as depression was found to be 
significantly predictor for changes on negative symptoms over time and improved 
the model fit considerably, the research was in line with previous suggestions of a 
relationship between depression and negative symptoms (Upthegrove et al., 2017). It 
was also found that internalised stigma seemed to contribute to negative symptoms 
which parallels previous research (Hill & Startup 2013; Lysaker, Vohs, & Tsai, 
2009; Staring et al., 2013) and supports the cognitive model of negative symptoms. 
It is hence likely that interventions addressing depression, internalised stigma, and 
reflective functioning would have a positive impact on negative symptoms.  
 
4.3. Evaluation of MLM 
 
The statistical analysis applied in the study illustrated the benefits of using MLM for 
case series as it accounted for the nested and auto-regressive nature of the data. 
MLM also had the advantage that it was able to manage data collected at various 
time points and with missing data.  
 
As with all small N designs, the risk of Type I and Type II error should be 
acknowledged due to the small sample size. Power in this study could have been 
increased by having more time points, or as recommended by Shadish et al (2013), 
or by recruiting more subjects. As the MLM in the current study included data from 
15 participants, it was larger than any of the case series included in the survey by 
Shadish & Sullivan (2011), where the maximum observed cases were 13 and the 
median was three. However, as described by the Shadish et al., (2013), more 
research is  needed to clarify the issue of power when using MLM for small N. This 
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would differ from previous research as the aim would be to gain enough power to 
detect a within-person treatment effect rather than a between-groups effect. Due to 
the uncertainty in relation to power in MLM, the current study focused on 
improvements in model fit in addition to the findings that reached statistical 
significance. This provided important information about the mechanisms of change 
in relation to improvements in negative symptoms and quality of life.  
 
4.4. Strengths and limitations 
 
The current study developed Metacognitive Training for Negative Symptoms and 
evaluated the intervention. The triangulation of quantitative and qualitative results 
supports the feasibility of the intervention. The study has clinical implications as it 
shows that negative symptoms are affected by psychological factors which can be 
improved in therapy. The promising results in terms of outcomes suggest the 
intervention should be systematically assessed in future research.  
 
In addition, the pilot study is also the first of its kind to identify mechanisms of 
change by including multiple models and factors (i.e. internalised stigma, reflective 
functioning, depression). This is important as previous studies evaluating 
psychosocial interventions for negative symptoms have targeted one specific area in 
isolation for intervention and outcome measures which is unlikely to fully explain 
the complexity of negative symptoms. The study also adds to the growing evidence 
base indicating the suitability of applying multilevel modeling for case series.  
A strength of the study is that it is a real life study and hence shows how effective 
the intervention is in routine circumstances. Furthermore, the patient group used in 
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this study had positive symptoms, depression, substance abuse, and extrapyramidal 
symptoms; this is a representative sample of a chronic treatment resistant group in 
standard care. This means that the findings of this study have high generalisability 
compared to an RCT which would have a highly selected group. For example, 65% 
of the population did not fulfil the inclusion criteria in the study by Klingberg et al., 
(2012) whilst a screen failure rate of 44% was found in the study by Velligan et al., 
(2015) after a month.  
 
The study has some obvious limitations due to its sample size limiting the ability to 
perform more sophisticated analyses (e.g. interactions between predictors). The absence 
of multiple baseline measurements also mean it is not possible to assess whether 
changes in symptoms were a result of treatment or chance. In addition, it would have 
been preferable if an independent researcher had administered the outcome 
measurements as this would have controlled for potential biases. As all participants 
received treatment as usual whilst taking part in the intervention, it is possible that 
improvements were due to care that they received from other sources (e.g. medication, 
psychological intervention, and nursing care) which may have influenced the outcome 
measures. It was encouraging that the qualitative data indicated that the metacognitive 
training was valued, and that participants reported that change had occurred as a result 
of this intervention.   
 
4.5. Overall conclusion 
 
The study shows that negative symptoms are affected by psychological factors (e.g. 
internalised stigma, reflective functioning, depression) and that these processes can be 
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improved in therapy. The promising results in terms of outcomes suggest the 
intervention should be systematically assessed in future research with a larger sample, a 
control group, and an independent research group. In addition, the study shows that 
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Appendix A. Exclusion criteria for the systematic review 
(modified from Ross et al., 2013 and Geddes, 2013) 
1. Hornsveld (2005) No measure of subjective wellbeing 
2. Hornsverld (2008) Patient group (PD rather than psychosis) 
3. Ahmed (2015) Patient group (included non-forensic 
population) 
4. Aho-Mustonen (2008) Patient group (included non-forensic 
population) 
5. Aho-Mustonen (2010) No measure of subjective wellbeing 
6. Axer (1995) No quantitative measure 
7. Clarke (2010) No measure of subjective wellbeing 
8. Cullen (2012 a,b) No measure of subjective wellbeing 
9. Dean (2013) Not published in peer-reviewed journal 
10. Fahy (2004) Not published in peer-reviewed journal 
11. Garrett (2007) No quantitative measure 
12. Haddock (2009) Not in a forensic setting 
13. Hall (2008) No measure of subjective wellbeing 
14. Hodel (2010) No measure of subjective wellbeing 
15. Kuokkanen (2014) No measure of subjective wellbeing 
16. Kunz (2014) No quantitative measure  
17. Long (2011) Patient group (PD rather than psychosis) 
18. Long (2008) No data reported 
19. Long (2012, 2013, 2015) Patient group (PD rather than psychosis) 
20. Luckhaus (2013) No measure of subjective wellbeing 
21. Naughton (2012) No measure of subjective wellbeing 
22. Nagi (2014) No measure of subjective wellbeing 
23. Mezey (2015) No quantitative measure 
24. Pilarc (2000) Not a forensic setting 
25. Ritchie (2011) Intervention designed to reduce substance 
abuse  
26. Ree-Jones (2012) No measure of subjective wellbeing 
27. Schanda (1992) Not in English 
28. Siess (2016) Not in English 
29. Sistig (2015) No measure of subjective wellbeing 
30. Slater (2016) No quantitative measure 
31. Tapp (2009)  No measure of subjective wellbeing 
32. Taylor (2016) No measure of subjective wellbeing 
33. Tibber (2015) No measure of subjective wellbeing 
34. Völlm (2017) Not published in peer-reviewed journal 
35. Walker (2012) No measure of subjective wellbeing 
36. Williams (2014) No measure of subjective wellbeing 
37. Wynaden (2012) No measure of subjective wellbeing 
38. Yates (2010) No quantitative measure 
39. Yip (2013) No measure of subjective wellbeing 
40. Young (2009) No measure of subjective wellbeing 
145 
 
Appendix B. Quality Assessment Tool 
 
Study Design and potential bias: 
 
1. Participants were randomly allocated with this process being sufficiently 
concealed: 
 




The method of allocation and concealment are mentioned 
but are not described in sufficient enough detail to be clear. 
Poorly addressed (1) The method of allocation or concealment are mentioned but 
are not sufficiently described. Alternatively, allocation is 
non-randomised. 
Not addressed (0) The method of allocation and/or concealment is not 
addressed. 
Not reported (0) The method of allocation and/or concealment is not 
reported. 
Not applicable (0) The method of allocation and/or concealment is not 
applicable in this study. 
 
2. An independent concealment of allocation procedure is used: 
 
Well covered (3)  Those administering the outcome measures were blind to 
the allocation of participants. Alternatively, different people 
administered the measures and delivered the intervention. 
The method of this being ensured is clearly described. 
Adequately addressed 
(2) 
The method of how researchers were blinded to allocation is 
described but is not sufficiently detailed in order to fully 
understand the method by which this was ensured. 
Poorly addressed (1) The blinding of researchers is mentioned but the method is 
not described. 
Not addressed (0) The blinding of researchers was not discussed. 
Not reported (0) The blinding of researchers was not reported. 
Not applicable (0)  The blinding of researchers is not applicable to this study. 
 
3. Acceptable and comparable attrition rates between groups: 
 
Well covered (3)  Details are given regarding the drop out rates for both 
groups. These are similar for each group (from pre- post 




Details are given regarding the drop out rates for both 
groups. These rates are somewhat alike between groups 
(within 20% of each other and less than 30% of total 
participants from pre- to post-intervention). 









4. Follow-up assessment at a suitable time period completed: 
 
Well covered (3)  Described sufficiently well to determine that follow-up 
period after the intervention is reasonable. At least 6 months 
post end of intervention. Follow-up data must include 
outcome measures used at baseline. 
Adequately addressed 
(2) 
Described sufficiently well to determine that follow-up 
period after the intervention is adequate. At least 3-6 months 
post end of intervention. Follow-up data must include 
outcome measures used at baseline. 
Poorly addressed (1) Described sufficiently well to determine that follow-up 
period after the intervention is inadequate. Follow up less 
than 3 months post end of intervention. Follow-up data must 
include outcome measures used at baseline. 
Not addressed (0) Follow-up is mentioned but is not described in sufficient 
detail to determine time period. 
Not reported (0) Follow-up assessment not reported. 




5. Outcome measures for subjective wellbeing are evidenced to be both valid and 
reliable and psychometric values are specified by the authors: 
 
Well covered (3)  Outcome measures are used with their psychometric 
properties being well reported. Details of their validity and 




Outcome measures are used with their psychometric 
properties being reported less well. Details of their validity 
and reliability within a forensic psychiatric population are 
less clear. 
Poorly addressed (1) The use of outcome measures is mentioned but with little 
information given about the measures or their psychometric 
properties. 
Not addressed (0) The use of outcome measures is mentioned but no further 
information is provided. 
Not reported (0) The use of outcome measures is not reported. 




groups. There are high drop out rates in general or uneven 
drop out rates. 
Not addressed (0)  Dropout rates are mentioned but not clearly described.  
Not reported (0)  
Not applicable (0) 
Dropout rates are not reported. 





6. The outcome is relevant and meaningful to the intervention: 
 
Well covered (3)  The outcome is described and is relevant to both the 
intervention and the evaluation of this within the context of 
subjective wellbeing in forensic patients. 
Adequately addressed 
(2) 
The outcome is described but is less relevant either to the 
specific intervention being delivered or within the context of 
subjective wellbeing in forensic patients. 
Poorly addressed (1) The outcome is mentioned but is less well covered and its 
usefulness to the evaluation of the intervention or broader 
context of subjective wellbeing in forensic patients is less 
clearly described. 
Not addressed (0) The overall outcome is not related to the intervention 
specifically or the broader context of subjective wellbeing in 
forensic patients. 
Not reported (0) How the outcome is related to the intervention and 
evaluation is not reported. 
Not applicable (0) How the outcome is related to the intervention and 
evaluation is not applicable in this study. 
 
7. Study is adequately powered to detect the effect of the intervention: 
 
Well covered (3)  A power calculation was completed using a reasonable 
effect size estimation and is clearly reported along with 
sufficient sample size within each group. 
Adequately addressed 
(2) 
A power calculation is carried out, however, arbitrary effect 
size estimation used. 
Poorly addressed (1) Power calculation is completed, however, effect size 
estimation is not mentioned and no evidence of this having 
informed the sample size in each group. 
 
Not addressed (0) Power calculation not completed or paper failed to meet the 
power calculation with sufficient sample size meaning any 
difference is not statistically significant. 
Not reported (0) Power calculation is not reported. 
Not applicable (0) Power calculation is not applicable in this instance. 
 
8. Appropriate analysis for outcome measures used and p values, confidence 
intervals and effect sizes reported where appropriate: 
 
Well covered (3)  Method of quantitative analysis used provides meaningful 
results of outcome and the confidence intervals, p-values 
and effect sizes are reported where appropriate. The analysis 
is described in sufficient detail so as statistical significance 





The quantitative analysis used provides meaningful results, 
however, the details of this such as the p-values, confidence 
intervals and effect sizes are less well covered. 
Poorly addressed (1) The method of analysis used has not been well considered 
and does not provide the best presentation of results from 
the study. The p values, effect sizes and confidence intervals 
may have mentioned but are not sufficient in this case. 
Not addressed (0) There has not been any quantitative analysis used in this 
case, rather inconclusive findings have been provided. 
Not reported (0) The methods of analysis have not been reported. 
Not applicable (0) The methods of analysis are not applicable in this instance. 
Quality of reporting:  
9. The TREND, CONSORT and STROBE statement guidelines for reporting have 
been adhered to in the RCT's, non-randomised trials and observational studies 
(guidelines included within appendices): 
 
Well covered (3)  The reporting and layout of the article has strictly followed 
the relevant statement guideline. 
Adequately addressed 
(2) 
The layout of the article is not in exactly the same format as 
that provided by the relevant guideline; however, the 
content required by the guideline is present. 
Poorly addressed (1) The guideline of reporting has not been adhered to 
successfully. There is evidence that aspects of the guideline 
have been considered but has not been sufficiently followed. 
Not addressed (0) There is no evidence that the guideline has been considered 
when the article has been developed. 
Not applicable (0) Adherence to the relevant guideline is not applicable in this 
study. 
Quality of the intervention: 
10. The intervention has been appropriately defined: 
Well covered (3)  The intervention is covered in sufficient detail including 
reference to the theoretical underpinnings and the potential 
impact the intervention could have on subjective wellbeing. 
The content and procedures of the intervention are clearly 
described so as it could be replicated by the reader. 
Adequately addressed 
(2) 
The intervention is described in relatively sufficient detail, 
although is less well covered. The theoretical underpinnings 
and potential impact the intervention could have on 
subjective wellbeing is discussed but in less detail. The 
content and procedures are also mentioned but lack the 




Poorly addressed (1) The intervention is described; however, there is a lack of 
reference to the theoretical underpinnings and potential 
impact on subjective wellbeing. The content and procedures 
are not discussed. 
Not addressed (0) The aims of the intervention are mentioned but the 
underpinnings and procedures of the intervention are 
lacking. 
Not reported (0) Details of the intervention itself are not reported. 
Not applicable (0) Details of the intervention are not applicable in this study. 
 
 
11. The intervention is both sufficiently defined and delivered as planned (i.e. 
demonstrates good fidelity): 
 
Well covered (3)  Details of how the treatment was operationalised (e.g. 
treatment manual) are provided and adhered to, as are 
fidelity checks (e.g. supervision and/or reflective practice). 
Adequately addressed 
(2) 
Details of how the treatment was operationalised (e.g. 
treatment manual) are provided and adhered to but there are 
no fidelity checks. 
Poorly addressed (1) Details of how the treatment was operationalised are given 
but there is no evidence of this being adhered to and/or no 
evidence of fidelity checks 
Not addressed (0) Operationalisation of the intervention and/or fidelity checks 
are mentioned but no further detail is given. 
Not reported (0) Operationalisation of the intervention and/or fidelity checks 
are not reported. 
Not applicable (0) Operationalisation of the intervention and/or fidelity checks 





12. The intervention has been implemented in a way that would be considered 
routine practice: 
 
Well covered (3)  The intervention took place in a forensic psychiatric setting and 
the article discusses external validity and the relevance of the 
intervention to this setting. 
Adequately addressed 
(2) 
The paper describes external validity and the relevance of this 
intervention to a forensic psychiatric setting, however, the 
intervention did not take place in this setting. 
Poorly addressed (1) The paper does not discuss external validity and the intervention 
did not take place in a forensic psychiatric setting. 
Not addressed (0) Neither external validity nor intervention setting was addressed in 
the paper. 




Not applicable (0) Neither external validity nor intervention setting was applicable 
in this study. 
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Appendix D. The International Journal of Forensic Mental 
Health author guidelines 
> Formatting and templates 
Papers may be submitted in any standard file format, including Word and LaTeX. 
Figures should be saved separately from the text. The main document should be 
double-spaced, with one-inch margins on all sides, and all pages should be numbered 
consecutively. Text should appear in 12-point Times New Roman or other common 
12-point font.  
Style guidelines 
Submissions to International Journal of Forensic Mental Health should follow the 
style guidelines described in the APA Publication Manual (6th ed.). Merriam-
Webster’s Collegiate Dictionary (11th ed.) should be consulted for spelling. 
References 
References should be cited parenthetically in the text by author surname(s) and year, 
in accordance with APA Publication Manual guidelines. References should be listed 
in a separate section at the end of the main text. All references in the list should be 
ordered alphabetically by the first author’s surname. 
1.      Author details. Please include all authors’ full names, affiliations, postal 
addresses, and email addresses on the cover page. One author will need to be 
identified as the corresponding author, with their email address normally displayed 
in the published article. Authors’ affiliations are the affiliations where the research 
was conducted.  
2.      Abstract.  This summary of your article is normally no longer than 100 words.  
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3.      Keywords. Keywords are the terms that are most important to the article and 
should be terms readers may use to search.  Authors should provide 3 to 5 keywords.   
 
Appendix E. The Clinical Psychology & Psychotherapy 
author guidelines 
PREPARING THE SUBMISSION 
Title Page 
The title page should contain: 
 A short informative title containing the major key words. The title should not 
contain abbreviations;  
 A short running title of less than 40 characters; 
 The full names of the authors; 
 The author's institutional affiliations where the work was conducted, with a 
footnote for the author’s present address if different from where the work 
was conducted; 
Abstract 
Enter an abstract of up to 150 words for all articles. An abstract is a concise 
summary of the whole paper, not just the conclusions, and is understandable without 
reference to the rest of the paper. It should contain no citation to other published 
work 
Keywords 




The language of the journal is English. 12-point type in one of the standard fonts: 
Times, Helvetica, or Courier is preferred. Please double-line space your manuscript. 
Tables must be on separate pages after the reference list, and not be incorporated into 
the main text. Figures should be uploaded as separate figure files 
References 
References should be prepared according to the Publication Manual of the American 
Psychological Association (6th edition). This means in text citations should follow 
the author-date method whereby the author's last name and the year of publication 
for the source should appear in the text, for example, (Jones, 1998). The complete 
reference list should appear alphabetically by name at the end of the paper. Please 
note that for journal articles, issue numbers are not included unless each issue in the 
volume begins with page 1, and a DOI should be provided for all references where 
available. 
Tables 
Tables should be self-contained and complement, not duplicate, information 
contained in the text. They should be supplied as editable files, not pasted as images. 
Legends should be concise but comprehensive – the table, legend, and footnotes 
must be understandable without reference to the text. All abbreviations must be 
defined in footnotes. Footnote symbols: †, ‡, §, ¶, should be used (in that order) and 
*, **, *** should be reserved for P-values. Statistical measures such as SD or SEM 
should be identified in the headings. 
Figure Legends 
Legends should be concise but comprehensive – the figure and its legend must be 
understandable without reference to the text. Include definitions of any symbols used 




Although authors are encouraged to send the highest-quality figures possible, for 
peer-review purposes, a wide variety of formats, sizes, and resolutions are accepted.  
Appendices 
Appendices will be published after the references. For submission they should be 
supplied as separate files but referred to in the text. 
General Style Points 
The following points provide general advice on formatting and style. 
 
Abbreviations: In general, terms should not be abbreviated unless they are used 
repeatedly and the abbreviation is helpful to the reader. Initially, use the word in full, 
followed by the abbreviation in parentheses. Thereafter use the abbreviation only. 
Units of measurement: Measurements should be given in SI or SI-derived units.  
Numbers: numbers under 10 are spelled out, except for: measurements with a unit 
(8mmol/l); age (6 weeks old), or lists with other numbers (11 dogs, 9 cats, 4 gerbils). 
Trade Names: Chemical substances should be referred to by the generic name only. 
Trade names should not be used. Drugs should be referred to by their generic names. 
If proprietary drugs have been used in the study, refer to these by their generic name, 
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